{"gene":"GAB2","run_date":"2026-06-09T23:54:44","timeline":{"discoveries":[{"year":1998,"finding":"GAB2 (p97) was cloned and identified as a scaffolding protein that, upon cytokine/growth factor/antigen receptor stimulation, becomes tyrosyl phosphorylated and associates with SHP2 and other SH2 domain-containing proteins. Expression of p97 mutants unable to bind SHP2 blocks cytokine-induced c-fos promoter activation, inhibiting Elk1-mediated and STAT5-mediated transactivation without inhibiting MAPK activation, revealing a novel pathway to immediate-early gene activation.","method":"Cloning, co-immunoprecipitation, dominant-negative mutant expression, reporter gene assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, dominant-negative mutants, reporter assays) in the foundational characterization paper","pmids":["9885561"],"is_preprint":false},{"year":1999,"finding":"GAB2 contains an N-terminal pleckstrin homology (PH) domain and upon tyrosine phosphorylation physically interacts with SHP2 and GRB2. GAB2 has an inhibitory effect on Elk-1-dependent transcription triggered by dominant-active Ras or growth factor stimulation, while having a similar function to GAB1 in ERK activation, demonstrating uncoupling of ERK and Elk-1 signaling.","method":"Co-immunoprecipitation, reporter gene assays (Elk-1, SRE), dominant-active Ras overexpression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP plus functional reporter assays with multiple mutants, foundational paper","pmids":["10391903"],"is_preprint":false},{"year":2001,"finding":"GAB2 is essential for mast cell allergic responses: Gab2-/- mice show defective FcεRI-induced degranulation and cytokine gene expression. GAB2 is the principal activator of PI3K downstream of FcεRI, as PI3K-dependent signaling pathways are defective in Gab2-/- mast cells.","method":"Gab2 knockout mice, mast cell functional assays (degranulation, cytokine production), passive cutaneous and systemic anaphylaxis models, biochemical pathway analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with multiple orthogonal phenotypic and biochemical readouts, replicated in vivo","pmids":["11449275"],"is_preprint":false},{"year":2002,"finding":"BCR-ABL recruits GAB2 via a GRB2/GAB2 complex through BCR-ABL Tyr177. GAB2 tyrosine phosphorylation enables association of PI3K and SHP2 with GAB2/BCR-ABL, activating PI3K/AKT and RAS/ERK pathways. Gab2-/- bone marrow myeloid progenitors are resistant to BCR-ABL transformation; lymphoid transformation is diminished with increased apoptosis.","method":"Gab2 knockout mice, BCR-ABL Y177F mutant, co-immunoprecipitation, bone marrow transformation assays, proliferation/migration assays","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout combined with BCR-ABL point mutant and Co-IP, multiple orthogonal methods","pmids":["12124177"],"is_preprint":false},{"year":2001,"finding":"GAB2 is required for mast cell development and KitL/c-Kit signaling. Gab2-deficient mice show markedly reduced mast cell numbers, and Gab2-deficient BMMCs show impaired KitL-induced ERK and AKT activation.","method":"Gab2 knockout mice, bone marrow-derived mast cell cultures, ERK/AKT phosphorylation assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with multiple signaling readouts and in vivo phenotype","pmids":["11861309"],"is_preprint":false},{"year":2001,"finding":"GAB2 acts as a scaffolding adapter downstream of the M-CSF receptor Fms: it associates with GRB2, SHP2, p85/PI3K, SHIP, and SHC upon M-CSF stimulation. GAB2 overexpression enhanced MAPK activity and macrophage differentiation; a SHP2-binding-defective mutant inhibited differentiation and increased proliferation, demonstrating that GAB2-SHP2 interaction is essential for M-CSF-induced differentiation signaling.","method":"Co-immunoprecipitation, GAB2 overexpression and dominant-negative mutants, MAPK assays, differentiation assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — structure-function with multiple mutants and orthogonal functional readouts","pmids":["11287610"],"is_preprint":false},{"year":2001,"finding":"GAB2 regulates beta1-integrin signaling in hematopoietic cells: beta1 integrin cross-linking induces tyrosine phosphorylation of GAB2 and its association with Syk kinase, SHP-2, and PI3K p85. Overexpression of PH domain or SHP-2 binding-defective GAB2 mutants reduced cell adhesion, migration, and beta1-integrin-induced PI3K activation.","method":"Co-immunoprecipitation, GAB2 mutant overexpression, adhesion and migration assays, PI3K activity assays","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus functional assays, single lab, multiple methods","pmids":["11895767"],"is_preprint":false},{"year":2001,"finding":"GAB2 is a docking protein for SHP2 and PI3K downstream of the IL-2 receptor: phosphorylation of GAB2 depends on JAK3 (not Lck or Syk) and requires Tyr338 of the IL-2 receptor beta chain. GAB2 is the major SHP-2 and PI3K-associated 98-kDa protein in IL-2-activated lymphocytes; only IL-2 and IL-15 (not other gamma-c cytokines) induce GAB2 phosphorylation.","method":"Co-immunoprecipitation, IL-2 receptor mutants, JAK3 inhibition/knockout studies","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including receptor mutants and kinase-specific inhibitors/knockouts","pmids":["10849428"],"is_preprint":false},{"year":2001,"finding":"GAB2 is phosphorylated by ZAP-70 in T cells and negatively regulates TCR signaling. GAB2 co-precipitates with ZAP-70, LAT, and CD3ζ upon TCR stimulation. Overexpression inhibits NF-AT activation and IL-2 production; inhibitory function requires SHP-2 binding sites and PI3K binding capacity. The PH domain is required for plasma membrane localization.","method":"Co-immunoprecipitation, GAB2 overexpression in Jurkat cells and T cell hybridomas, NF-AT reporter assays, GAB2 mutant analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple mutants combined with functional and localization readouts in two T cell systems","pmids":["11572860"],"is_preprint":false},{"year":2002,"finding":"PKB/AKT constitutively associates with GAB2 and phosphorylates GAB2 on Ser159, providing negative feedback: Ser159 phosphorylation inhibits GAB2 tyrosine phosphorylation. Gab2-S159A mutant enhances HRG-induced tyrosine phosphorylation, amplifies ERK and PKB pathway activation, increases ErbB2 tyrosine phosphorylation, and has potent transforming activity in fibroblasts, establishing GAB2 as a proto-oncogene.","method":"In vitro kinase assay (PKB phosphorylation of GAB2 at Ser159), site-directed mutagenesis (S159A), co-immunoprecipitation, focus-forming assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay plus mutagenesis plus functional transformation assay, multiple orthogonal methods","pmids":["11782427"],"is_preprint":false},{"year":2002,"finding":"GAB2 mediates a negative regulatory role in FcεRI signaling in mast cells: upon FcεRI aggregation, GAB2 translocates from cytosol to plasma membrane and associates with SHP2, GRB2, Lyn, and PLCγ. Overexpression of GAB2 inhibited FcεRI-induced phosphorylation of Syk and MAPK, calcium mobilization, degranulation, and TNF-α/IL-6 gene expression, while leaving Akt phosphorylation unaffected.","method":"Co-immunoprecipitation, GAB2 overexpression in RBL-2H3 cells, calcium mobilization assay, degranulation assay, cytokine mRNA analysis","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus multiple functional readouts, single lab","pmids":["11971018"],"is_preprint":false},{"year":2002,"finding":"GAB2 interacts with SHP-2 via specific tyrosines: Y452, Y476, and Y584 mediate p85-PI3K binding; Y614 exclusively mediates SHP-2 binding; Y266 and Y293 mediate CrkL binding (via CrkL SH2). These interactions were mapped using a yeast two-hybrid system with Lyn kinase co-expression.","method":"Modified yeast two-hybrid with Lyn tyrosine kinase co-expression, tyrosine mutants","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic mutant mapping in yeast two-hybrid system, single lab","pmids":["11334882"],"is_preprint":false},{"year":2002,"finding":"In BCR-ABL+ K562 CML cells, GAB2 overexpression selectively activates the Erk2-Elk1 signaling pathway in a manner dependent on GAB2 Tyr604 (SHP2 docking site) and SHP2 phosphatase activity. Induced GAB2 expression promotes Erk activation, growth arrest, and megakaryocytic differentiation.","method":"Erk2-Elk1 reporter assays, inducible Gab2 expression, GAB2 Y604F mutant analysis, differentiation markers","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — structure-function with specific point mutants and multiple functional readouts, single lab","pmids":["11830491"],"is_preprint":false},{"year":2003,"finding":"GAB2 is required for FcγR-mediated phagocytosis in macrophages: upon FcγR activation, GAB2 becomes tyrosyl phosphorylated, associates with PI3K p85 and SHP2, and is recruited to the nascent phagosome where PI3K lipid production occurs. Gab2-/- macrophages show severely impaired FcγR phagocytosis correlating with decreased Akt activation. PH domain and GRB2-binding site of GAB2 are required for phagosome recruitment, and phagosome localization is sensitive to PI3K inhibition.","method":"Gab2 knockout mice, confocal fluorescence microscopy, co-immunoprecipitation, phagocytosis assays, wortmannin treatment, GAB2 mutant analysis","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout plus live imaging and mutant analysis with multiple orthogonal readouts","pmids":["12821647"],"is_preprint":false},{"year":2003,"finding":"GAB2 interacts with GC-GAP, a RhoA/Rac1/Cdc42 GTPase-activating protein, through its middle region. This interaction was identified by yeast two-hybrid screening and GC-GAP reduces active Rac1 and Cdc42 levels, suggesting GAB2 may regulate Rho family GTPase activity through GC-GAP recruitment.","method":"Yeast two-hybrid, co-immunoprecipitation, in vitro GAP activity assay, siRNA knockdown","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus in vitro GAP assay, single lab","pmids":["12819203"],"is_preprint":false},{"year":2003,"finding":"GAB2 inhibitory function in T cells requires Gads/Grb2-mediated association with LAT. The MBD domain of GAB2 contains a PXXXR motif that is critical for constitutive association with Gads/Grb2, which recruits GAB2 to lipid rafts after TCR ligation. Gab2-deficient T cells show enhanced proliferative responses to TCR stimulation.","method":"Gab2 knockout mice, GAB2 mutant analysis, co-immunoprecipitation, lipid raft fractionation, T cell transgenic mice","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout plus transgenic mice plus mutant analysis with multiple functional readouts","pmids":["12640133"],"is_preprint":false},{"year":2003,"finding":"In T cells, GAB2 delivers an inhibitory signal via PI3K: overexpression of GAB2 inhibits TCR-evoked IL-2 promoter activation (blocking NF-AT and NF-κB transcription). Inhibition is abrogated by mutating GAB2 p85-binding sites or by PI3K inhibitor treatment.","method":"GAB2 overexpression in T cell lines, reporter gene assays (IL-2 promoter, NF-AT, NF-κB), PI3K inhibitors, GAB2 p85-binding site mutants","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — structure-function with mutants and pharmacological inhibitors, single lab","pmids":["11035047"],"is_preprint":false},{"year":2004,"finding":"SHP2 binds GAB2 at Tyr614 via its N-terminal SH2 domain (and Tyr643 via C-terminal SH2, though Y614F mutation alone prevents SHP2 recruitment). This SHP2-GAB2 interaction is required for ERK activation and c-fos SRE transcriptional induction in response to IL-2. GAB2/SHP2-mediated ERK activation and Rho-dependent signals cooperate for full SRE induction.","method":"Co-immunoprecipitation with Tyr→Phe mutants, ERK activation assays, SRE reporter assays, dominant-active/dominant-negative RhoA","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-directed mutagenesis combined with functional reporter assays, single lab","pmids":["15170389"],"is_preprint":false},{"year":2004,"finding":"Hematopoietic cell kinase (Hck) phosphorylates GAB1 and GAB2 in response to IL-6, and this Src-family kinase-dependent phosphorylation is required for IL-6-induced ERK and AKT activation and multiple myeloma cell proliferation/survival.","method":"Src family kinase inhibitor PP2, kinase-inactive Hck mutants, kinase assays, proliferation/survival assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase-inactive mutants plus pharmacological inhibition with functional readouts, single lab","pmids":["15010462"],"is_preprint":false},{"year":2005,"finding":"GAB2 is the principal scaffold for RANK-induced NF-κB, Akt, and Jnk activation in osteoclastogenesis. Gab2-/- mice develop osteopetrosis with defective osteoclast differentiation. GAB2 associates with RANK and mediates RANK signaling to these downstream pathways.","method":"Gab2 knockout mice (osteopetrosis phenotype), co-immunoprecipitation with RANK, osteoclast differentiation assays, NF-κB/Akt/Jnk signaling assays","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with in vivo bone phenotype plus Co-IP and signaling assays, multiple orthogonal methods","pmids":["15750601"],"is_preprint":false},{"year":2005,"finding":"In breast cancer, GAB2 overexpression increases proliferation and invasion of mammary epithelial cells; invasive phenotype with HER2 (Neu) is mediated by hyperactivation of the SHP2-ERK pathway. Gab2 deficiency ameliorates Neu-evoked breast carcinogenesis in mice.","method":"3D Matrigel culture, co-expression with Neu, Gab2 knockout in Neu-transgenic mouse model, signaling pathway analysis","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO in mouse cancer model plus 3D culture functional assays plus signaling, multiple orthogonal methods","pmids":["16369543"],"is_preprint":false},{"year":2005,"finding":"GAB2 overexpression in MCF-10A cells enhances EGF-induced ERK and AKT activation, increases acinar size in 3D culture dependent on GRB2 and SHP2 binding, and overcomes EGF dependence. A GAB2 mutant unable to bind p85/PI3K has reduced effect on acinar size. These effects establish GAB2 as an amplifier of RTK signaling.","method":"3D Matrigel morphogenesis assay, GAB2 mutants (Grb2 binding, Shp2 binding, p85 binding), pharmacological MEK inhibition, signaling assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — structure-function with multiple domain-specific mutants and 3D functional assays, single lab with multiple orthogonal methods","pmids":["16253990"],"is_preprint":false},{"year":2005,"finding":"Activated STAT5 promotes constitutive GAB2 tyrosine phosphorylation independent of JAK2, and GAB2 forms a complex with STAT5, p85/PI3K, and GRB2 (but not SHP2) in this context. A GAB2 mutant lacking PI3K binding sites (3YF) inhibits caSTAT5-induced proliferation, survival, and ERK/AKT activation, establishing GAB2 as essential for STAT5-driven PI3K/Akt and Ras/MAPK signaling.","method":"Co-immunoprecipitation, GAB2-3YF mutant overexpression, constitutively active STAT5 expression, proliferation/survival assays","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus functional mutant analysis, single lab","pmids":["15833084"],"is_preprint":false},{"year":2006,"finding":"PLCγ2 forms a complex with GAB2 in osteoclasts, is required for RANKL-mediated phosphorylation of GAB2, and modulates GAB2 recruitment to RANK. PLCγ2-dependent NFATc1 upregulation (but not JNK and NF-κB) requires Dap12/FcRγ receptors and is blocked by PLCγ inhibitor. PLCγ2 deletion results in osteopetrosis.","method":"Plcg2 knockout mice, co-immunoprecipitation, PLCγ inhibitor U73122, osteoclast differentiation assays, NFATc1 activation assays","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout plus Co-IP plus pharmacological inhibition with multiple signaling readouts","pmids":["17053833"],"is_preprint":false},{"year":2006,"finding":"GAB2 requires SHP2 to activate the Rac/JNK pathway downstream of Kit Tyr567 in mast cells for SCF-evoked proliferation. GAB2 becomes tyrosyl-phosphorylated and associates with Kit and SHP2 upon Kit activation. SFK activity (via Tyr567) is required for GAB2 tyrosyl phosphorylation and SHP2 association. GAB2 acts in a parallel pathway to PI3K from Kit Tyr719.","method":"Gab2-/- mast cells, Gab2/SHP2 double conditional knockouts, compound Gab2-/-:KitY719F/Y719F mice, GAB2 mutants (SHP2-binding defective), JNK/Rac activation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models plus structure-function mutants plus rescue experiments","pmids":["16873377"],"is_preprint":false},{"year":2007,"finding":"GAB2 knockdown increases tau phosphorylation in neurons, suggesting GAB2 negatively regulates tau phosphorylation. GAB2 protein is detected in neurons, tangle-bearing neurons, and dystrophic neurites in Alzheimer's disease brain.","method":"siRNA knockdown of GAB2, immunohistochemistry/immunofluorescence in human brain tissue","journal":"Neuron","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single siRNA experiment with indirect tau phosphorylation readout, single lab","pmids":["17553421"],"is_preprint":false},{"year":2007,"finding":"GAB2 is required for mammary tumor metastasis downstream of Neu/ErbB2: Gab2-/- cancer cells show decreased migration and impaired ERK activation; defects are rescued by re-introduction of Gab2. Gab2 ablation severely suppresses lung metastasis with normal Akt activity, indicating a specific role for GAB2-ERK in metastasis.","method":"Gab2 knockout in Neu-transgenic mouse breast cancer model, GAB2 re-expression rescue, migration assays, ERK/AKT signaling assays, lung metastasis quantification","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout in mouse cancer model plus rescue experiment plus multiple signaling readouts","pmids":["17310989"],"is_preprint":false},{"year":2007,"finding":"A novel Stat3 binding site in Gab2 mediates activation of Stat3 by Sf-Stk receptor tyrosine kinase (Friend virus-associated). Grb2-mediated recruitment of GAB2 (but not GAB1) to Sf-Stk supports expansion of infected erythroid progenitors. Gab2-/- mice are less susceptible to Friend erythroleukemia.","method":"Gab2 knockout mice, Sf-Stk/Gab2 fusion proteins, Stat3 reporter assays, co-immunoprecipitation","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus novel binding site identification with functional assays, single lab","pmids":["17353274","16314834"],"is_preprint":false},{"year":2008,"finding":"14-3-3 proteins bind GAB2 at growth factor-induced phosphorylation sites Ser210 and Thr391, providing negative feedback. The Gab2-S210A/T391A double mutant shows sustained receptor association and signaling and promotes cell proliferation and transformation. Introduction of constitutive 14-3-3 binding sites into GAB2 renders it refractory to receptor activation. 14-3-3 binding reduces Grb2 association, uncoupling GAB2 from the receptor complex.","method":"Mass spectrometry phosphoproteomics, site-directed mutagenesis (S210A/T391A), constitutive 14-3-3 binding site knock-in, co-immunoprecipitation, proliferation/transformation assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — phosphoproteomics plus mutagenesis plus functional transformation assays, multiple orthogonal methods","pmids":["19172738"],"is_preprint":false},{"year":2008,"finding":"Lyn kinase (BCR-ABL-independent) forms a complex with GAB2 and c-Cbl in imatinib-resistant CML cells and mediates persistent GAB2 and BCR-ABL tyrosine phosphorylation. Lyn silencing or inhibition is required to suppress GAB2 phosphorylation and recover imatinib sensitivity.","method":"Co-immunoprecipitation, siRNA knockdown, Lyn kinase inhibitors, imatinib sensitivity assays in CML cells and patient samples","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus siRNA knockdown plus pharmacological inhibition, single lab","pmids":["18235045"],"is_preprint":false},{"year":2008,"finding":"GAB2 is involved in differential PI3K signaling by two splice forms of c-Kit (GNNK- vs GNNK+): GNNK- c-Kit mediates stronger PI3K/AKT activation dependent on GAB2 association. Src-mediated phosphorylation of GAB2 is independent of direct PI3K association with c-Kit. siRNA knockdown of GAB2 confirms its role in c-Kit-induced PI3K/AKT activation.","method":"siRNA knockdown of Gab2, c-Kit splice variant expression, co-immunoprecipitation, PI3K/AKT activation assays, Src inhibitor studies","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA plus Co-IP plus splice variant comparison, single lab","pmids":["18697750"],"is_preprint":false},{"year":2009,"finding":"Two distinct epitopes in GAB2 (Gab2a and Gab2b) bind the Grb2 SH3C domain with different binding modes. Crystal structures reveal that Gab2b contains a 3(10) helix positioning an RxxK motif, while Gab2a contains the RxxK motif in a PPII helix. These define the molecular basis of GAB2-GRB2 interaction.","method":"Crystal structures of Gab2a/Grb2SH3C and Gab2b/Grb2SH3C complexes, isothermal titration calorimetry, peptide arrays","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures combined with ITC quantification, rigorous structural and biochemical validation","pmids":["19523899"],"is_preprint":false},{"year":2009,"finding":"GAB2-mediated signaling promotes melanoma metastasis via PI3K-AKT hyperactivation. GAB2 overexpression potentiates migration and invasion; knockdown reduces them. PI3K-AKT pathway inhibition decreases GAB2-mediated tumor cell migration. GAB2 overexpression enhances in vivo tumor growth and metastasis.","method":"GAB2 siRNA knockdown, GAB2 overexpression, PI3K inhibitor treatment, in vitro migration/invasion assays, in vivo xenograft model","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function and gain-of-function with in vivo validation, single lab","pmids":["19342374"],"is_preprint":false},{"year":2009,"finding":"RANK contains a highly conserved domain (HCR) that recruits GAB2, which then associates with PLCγ2, mediating sustained NF-κB activation and PLCγ2/NFATc1 activation during late-phase RANK signaling essential for osteoclastogenesis.","method":"Co-immunoprecipitation with RANK HCR domain mutants, RANK-deletion constructs, NF-κB and NFATc1 reporter assays, osteoclast differentiation","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mutant analysis plus Co-IP plus functional signaling assays, single lab","pmids":["19845770"],"is_preprint":false},{"year":2010,"finding":"GAB2 suppresses RhoA activation via SHP2-dependent promotion of Vav2 phosphorylation and p190A RhoGAP plasma membrane recruitment. GAB2 overexpression decreases stress fibers and focal adhesions and enhances migration; effects are reversed by constitutively active RhoA or p190A RhoGAP knockdown. Both SHP2 binding sites in GAB2 are required for these effects.","method":"GAB2 overexpression, GAB2 mutants (SHP2-binding site mutations), RhoA/Rac-GTP pull-down assays, constitutively active RhoA rescue, p190A RhoGAP knockdown, cell morphology/migration assays","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — structure-function mutants plus RhoA/Rac activity assays plus multiple rescue experiments, multiple orthogonal methods","pmids":["21118992"],"is_preprint":false},{"year":2011,"finding":"GAB2 via PI3K regulates ARF1 activation downstream of FcεRI for granule translocation in mast cell degranulation. GAB2 knock-in mice (mutated at PI3K or SHP2 binding sites) show both sites required for degranulation and anaphylaxis; PI3K (not SHP2) binding site is required for granule translocation. Fyn and GAB2/PI3K upstream of ARF1 constitute the pathway. SHP2 binding site is dispensable for granule translocation but required for degranulation.","method":"GAB2 knock-in mice (PI3K-binding-defective and SHP2-binding-defective), ARF1 activation assay, FcεRI degranulation assays, anaphylaxis model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — precise knock-in mice plus ARF1 activity assays plus in vivo functional readouts, multiple orthogonal methods","pmids":["21653832"],"is_preprint":false},{"year":2011,"finding":"G-CSF activates Lyn kinase through a Gab2-Shp2 complex: after G-CSF stimulation, Lyn dynamically associates with Gab2; Shp2 recruited by Gab2 dephosphorylates inhibitory phospho-Lyn Tyr507 to activate Lyn. A GAB2 mutant unable to bind Shp2 prevents Tyr507 dephosphorylation.","method":"Co-immunoprecipitation, Shp2-deficient cells, Shp2E76A constitutively active mutant, in vitro dephosphorylation assay, GAB2 Shp2-binding mutant","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro phosphatase assay plus genetic and mutant approaches, multiple orthogonal methods","pmids":["21636860"],"is_preprint":false},{"year":2011,"finding":"In ovarian cancer cells, GAB2 promotes migration, invasion, and EMT via activation of the PI3K pathway. GAB2 inhibits E-cadherin expression and enhances Zeb1 expression through PI3K, not the Shp2-ERK pathway; Zeb1 knockdown blocks GAB2-induced E-cadherin suppression and invasion.","method":"GAB2 overexpression and knockdown, GAB2 mutants (PI3K-binding defective, SHP2-ERK pathway defective), Zeb1 knockdown, PI3K inhibitors (LY294002, GDC-0941, rapamycin), migration/invasion assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — structure-function mutants plus pathway-specific inhibitors plus downstream target knockdown, multiple orthogonal approaches","pmids":["21996746"],"is_preprint":false},{"year":2012,"finding":"PKA phosphorylates GAB2 on Ser159, and GAB2 acts as an A-kinase anchoring protein that binds the type I regulatory subunit of PKA. GAB2 is present in a preformed complex with PI3K heterodimer and IRS-1 in granulosa cells. GAB2 overexpression enhances FSH-stimulated AKT phosphorylation, connecting cAMP-PKA signaling to the PI3K/AKT pathway.","method":"Co-immunoprecipitation (PKA regulatory subunit with GAB2), GAB2 overexpression, FSH-stimulated AKT phosphorylation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus functional overexpression assay, single lab, novel mechanism","pmids":["23045700"],"is_preprint":false},{"year":2013,"finding":"RSK (p90 ribosomal S6 kinase) phosphorylates GAB2 on three conserved basic consensus residues in vitro and in vivo, inhibiting SHP2 recruitment to GAB2 without affecting GRB2 binding. An unphosphorylatable GAB2 mutant promotes invasion-like phenotype and increased cell motility, establishing RSK as a negative-feedback kinase for GAB2-SHP2 signaling.","method":"In vitro kinase assay (RSK phosphorylating GAB2), mass spectrometry phosphorylation site mapping, site-directed mutagenesis, co-immunoprecipitation, cell motility assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay plus MS site mapping plus mutagenesis plus functional assays, multiple orthogonal methods","pmids":["23401857"],"is_preprint":false},{"year":2015,"finding":"A small-molecule (ISIR-005) stabilizes the 14-3-3/GAB2 protein-protein interaction by binding at the rim of the interface near the Gab2pT391 binding site. Crystal structure reveals ISIR-005 occupies a pre-formed pocket only at the pT391 site (not the pS210 site), providing structural proof of druggability of this interaction.","method":"Crystal structure of ISIR-005/14-3-3/Gab2pS210pT391, isothermal titration calorimetry","journal":"ChemMedChem","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with biochemical validation by ITC, rigorous structural evidence","pmids":["26644359"],"is_preprint":false},{"year":2016,"finding":"GAB2 interaction with mutant SHP2 (E76K/D61Y) is enhanced, and the Gab2/PI3K/mTOR pathway is elevated in Ptpn11E76K/+ leukemic cells. Double mutant Ptpn11E76K/+/Gab2-/- mice show markedly attenuated myeloproliferative neoplasia, normalized myeloid differentiation, and prolonged survival. Rapamycin treatment mitigates MPN phenotypes, confirming the mTOR pathway mediates pathogenic signaling.","method":"Ptpn11E76K/+/Gab2-/- double mutant mice, rapamycin treatment, co-immunoprecipitation, myeloid colony assays, histology","journal":"Leukemia","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic double mutant mice plus pharmacological validation plus Co-IP, multiple orthogonal methods","pmids":["27840422"],"is_preprint":false},{"year":2016,"finding":"In BCR-ABL1 leukemogenesis, distinct GAB2 signaling pathways are required for myeloid vs. lymphoid transformation: both PI3K and SHP2 binding sites of GAB2 are required for CML pathogenesis, while only the SHP2 binding site is essential for lymphoid leukemogenesis. Gab2-/- mice fail to develop CML-like disease after BCR-ABL1 transduction.","method":"Gab2-/- mouse models of CML and B-ALL, GAB2 mutants (PI3K binding-defective, SHP2 binding-defective), GAB2 re-expression rescue, signaling analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus rescue with domain-specific mutants in two distinct disease models, multiple orthogonal methods","pmids":["26773044"],"is_preprint":false},{"year":2017,"finding":"YAP/TAZ transcription regulators upregulate GAB2 expression; coordinate knockdown of YAP and TAZ markedly decreases GAB2 protein levels and reduces PI3K pathway activation in endometrial cancer cells, establishing a HIPPO-YAP/TAZ-GAB2-PI3K signaling axis.","method":"siRNA knockdown of YAP and TAZ, GAB2 protein level measurement, PI3K/AKT pathway assays, in vivo tumor growth","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with signaling readouts and in vivo validation, single lab","pmids":["28202507"],"is_preprint":false},{"year":2017,"finding":"GAB2 overexpression in zebrafish MYCN-transgenic neuroblastoma activates the SHP2-RAS-ERK pathway, enhances neuroblastoma induction, and increases tumor penetrance. GAB2 functions as an activator of SHP2 that cooperates with MYCN in neuroblastomagenesis.","method":"Zebrafish MYCN transgenic model with Gab2 overexpression, ERK pathway activation analysis, tumor penetrance/latency assessment","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo zebrafish model plus signaling analysis, single lab","pmids":["28329685"],"is_preprint":false},{"year":2017,"finding":"Gab1 and Gab2 are recruited to the IL-4 receptor and synergistically enhance IL-4 downstream signaling but confer IL-4 signal preference in macrophages. Loss of Gab2 specifically suppresses STAT6 activation (while Gab1 loss attenuates AKT) in response to IL-4, defining non-redundant roles in M2 polarization.","method":"Gab2-/- mice, Gab1 conditional knockout in macrophages, IL-4 signaling assays (STAT6, AKT), M2 polarization markers, bleomycin fibrosis model, co-immunoprecipitation with IL-4 receptor","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockouts for both Gab1 and Gab2 with multiple signaling readouts and in vivo phenotype","pmids":["28687632"],"is_preprint":false},{"year":2022,"finding":"GAB2 facilitates assembly of the CBM (CARMA3-BCL10-MALT1) signalosome in endothelial cells, mediating Rho and NF-κB activation downstream of IL-1β. GAB2 silencing or MALT1 inhibition reduces IL-1β-induced Rho-dependent P-selectin/VWF exocytosis and NF-κB-dependent tissue factor expression. Gab2 deficiency suppresses venous thrombosis in IVC ligation mouse models.","method":"siRNA knockdown of Gab2 and MALT1, MALT1 pharmacological inhibitor (mepazine), co-immunoprecipitation (CBM signalosome assembly), endothelial exocytosis/adhesion assays, IVC ligation stenosis/stasis mouse models","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockdown plus pharmacological inhibition plus Co-IP plus in vivo mouse model, multiple orthogonal methods","pmids":["35895897"],"is_preprint":false}],"current_model":"GAB2 is a scaffolding/docking protein that, upon tyrosine phosphorylation by receptor-associated kinases (including Src/Lyn, ZAP-70, JAK2, JAK3, Hck, and RSK), recruits SHP2, PI3K (p85), GRB2, PLCγ, CrkL, and other SH2-domain proteins to activate the PI3K/AKT and RAS/ERK/SHP2 signaling cascades downstream of diverse receptors (FcεRI, RANK, c-Kit, BCR-ABL, EGFR/HER2, IL-2R, G-CSFR, and others); its activity is negatively regulated by PKB/AKT-mediated Ser159 phosphorylation, by 14-3-3 binding at Ser210/Thr391 (which disrupts GRB2 association and receptor coupling), and by RSK-mediated phosphorylation that blocks SHP2 recruitment, while GAB2 itself uses its PH domain for membrane/phagosome localization, its MBD/PXXXR motif for Gads/GRB2-mediated LAT recruitment, and its SHP2-binding sites to activate the Rac/JNK pathway, promote RhoA suppression via p190A RhoGAP, facilitate CBM signalosome assembly for NF-κB/Rho activation, and ultimately control mast cell allergic responses, osteoclastogenesis, FcγR phagocytosis, hematopoietic cell proliferation/differentiation, and tumor metastasis."},"narrative":{"mechanistic_narrative":"GAB2 is a tyrosine-phosphorylated scaffolding/docking protein that couples diverse cytokine, antigen, growth-factor, and integrin receptors to the PI3K/AKT and SHP2/RAS/ERK signaling cascades, thereby controlling hematopoietic differentiation, mast-cell allergic responses, osteoclastogenesis, phagocytosis, and tumorigenesis [PMID:9885561, PMID:11449275, PMID:16369543]. Upon receptor engagement GAB2 is recruited to the membrane through its N-terminal PH domain and through GRB2/Gads binding to a PXXXR motif in its MBD, and once tyrosine-phosphorylated it assembles SH2-domain effectors—SHP2 at Tyr614, p85/PI3K at multiple tyrosines, GRB2, CrkL, and PLCγ—into signaling complexes [PMID:10391903, PMID:11572860, PMID:11334882, PMID:12821647, PMID:12640133, PMID:19523899]. The SHP2-binding sites drive ERK activation and immediate-early gene transcription, activate the Rac/JNK pathway, and suppress RhoA via Vav2/p190A RhoGAP, while the PI3K-binding sites mediate AKT activation, granule translocation, and EMT, allowing GAB2 to partition signaling into distinct biological outputs [PMID:15170389, PMID:16873377, PMID:21118992, PMID:21653832, PMID:21996746]. GAB2 is the principal PI3K activator downstream of FcεRI in mast cells, is required for c-Kit/SCF, M-CSF, RANK, IL-2/IL-4, BCR-ABL, and STAT5 signaling, and serves as the scaffold for RANK-driven NF-κB/Akt/JNK in osteoclasts and for CBM-signalosome assembly mediating IL-1β-induced Rho/NF-κB responses [PMID:11449275, PMID:11861309, PMID:11287610, PMID:15750601, PMID:35895897]. GAB2 functions as a proto-oncogene amplifying RTK signaling: its overexpression promotes proliferation, invasion, and metastasis in breast, ovarian, melanoma, and neuroblastoma models, and its loss attenuates Neu/ErbB2-driven carcinogenesis and BCR-ABL/Ptpn11-mutant leukemias [PMID:11782427, PMID:16369543, PMID:17310989, PMID:27840422, PMID:26773044]. GAB2 activity is restrained by multiple negative-feedback phosphorylation events: AKT/PKA phosphorylation at Ser159, 14-3-3 binding at Ser210/Thr391 that uncouples GAB2 from GRB2 and the receptor, and RSK phosphorylation that selectively blocks SHP2 recruitment [PMID:11782427, PMID:19172738, PMID:23401857].","teleology":[{"year":1998,"claim":"Established GAB2's foundational identity as a receptor-induced scaffold whose SHP2 association is required to drive immediate-early gene transcription, defining a signaling route distinct from MAPK.","evidence":"Cloning, Co-IP, and dominant-negative SHP2-binding mutants with c-fos/Elk1/STAT5 reporters","pmids":["9885561"],"confidence":"High","gaps":["Did not define which tyrosines mediate SHP2 binding","Physiological receptor contexts not yet established"]},{"year":1999,"claim":"Defined the modular architecture (N-terminal PH domain, phospho-dependent SHP2 and GRB2 binding) and showed GAB2 uncouples ERK from Elk-1 signaling.","evidence":"Reciprocal Co-IP plus Elk-1/SRE reporter assays with dominant-active Ras","pmids":["10391903"],"confidence":"High","gaps":["Membrane-targeting mechanism of the PH domain not resolved","Physiological receptor input undefined"]},{"year":2000,"claim":"Identified GAB2 as the dominant IL-2R-coupled SHP2/PI3K docking protein, linking it to a specific receptor (Tyr338 of IL-2Rβ) and kinase (JAK3).","evidence":"Co-IP, IL-2 receptor mutants, JAK3 inhibition/knockout in lymphocytes","pmids":["10849428"],"confidence":"High","gaps":["Downstream functional consequence in primary lymphocytes not addressed","Cytokine specificity mechanism unexplained"]},{"year":2001,"claim":"Genetic knockouts revealed GAB2 as a non-redundant, receptor-specific scaffold: it is the principal FcεRI-coupled PI3K activator in mast cells and required for c-Kit and M-CSF-driven differentiation, while in T cells it negatively regulates TCR signaling.","evidence":"Gab2-/- mice with mast-cell degranulation/anaphylaxis and KitL/M-CSF signaling assays; Co-IP and mutant analysis in Jurkat/hybridoma T cells","pmids":["11449275","11861309","11287610","11572860","11895767","11035047"],"confidence":"High","gaps":["Mechanistic basis for opposite (positive vs negative) signaling outputs across cell types unresolved","Membrane recruitment requirements not fully mapped"]},{"year":2002,"claim":"Mapped the specific tyrosines coupling GAB2 to effectors and established GAB2 as a proto-oncogene under AKT negative feedback, while implicating it in BCR-ABL leukemogenesis.","evidence":"Yeast two-hybrid tyrosine mapping; in vitro PKB kinase assay with S159A mutant and focus-forming assay; Gab2-/- bone marrow BCR-ABL transformation with Y177F mutant","pmids":["11334882","11782427","12124177","11830491","11971018"],"confidence":"High","gaps":["How Ser159 phosphorylation mechanistically suppresses tyrosine phosphorylation not detailed","Whether negative-feedback loops operate in all receptor contexts unknown"]},{"year":2003,"claim":"Resolved GAB2 membrane/phagosome recruitment logic and the LAT-coupling mechanism, and linked GAB2 to Rho-family GTPase regulation.","evidence":"Gab2-/- macrophage phagocytosis with confocal imaging and PH/GRB2 mutants; Gads/Grb2 PXXXR-motif raft recruitment in T cells; yeast two-hybrid identification of GC-GAP","pmids":["12821647","12640133","12819203"],"confidence":"High","gaps":["Direct contribution of GC-GAP to GAB2-dependent GTPase output in cells not established","Spatial coordination of PI3K-dependent recruitment with effector assembly incomplete"]},{"year":2004,"claim":"Pinpointed Tyr614 as the critical SHP2-docking site required for ERK activation and identified Src-family kinase (Hck) phosphorylation as essential for IL-6-driven GAB2 signaling.","evidence":"Tyr-to-Phe Co-IP mutants with ERK/SRE assays; kinase-inactive Hck and PP2 inhibition in myeloma cells","pmids":["15170389","15010462"],"confidence":"Medium","gaps":["Single-lab studies without genetic confirmation","Relative contribution of Tyr614 vs Tyr643 not fully separated"]},{"year":2005,"claim":"Established GAB2 as a tissue-level disease scaffold: essential for RANK-driven osteoclastogenesis, an amplifier of RTK signaling in breast epithelium, and a driver of ErbB2/Neu-evoked carcinogenesis, while also coupling to STAT5.","evidence":"Gab2-/- osteopetrosis mice with RANK Co-IP; 3D MCF-10A morphogenesis with domain mutants; Gab2-/- in Neu-transgenic breast cancer; STAT5/PI3K Co-IP with 3YF mutant","pmids":["15750601","16369543","16253990","15833084"],"confidence":"High","gaps":["Why specific receptors route through PI3K vs SHP2 arms not mechanistically unified","STAT5-driven GAB2 phosphorylation kinase identity uncertain"]},{"year":2006,"claim":"Dissected the SHP2-dependent Rac/JNK arm downstream of Kit and the PLCγ2 requirement for RANK signaling, separating parallel PI3K and SHP2 pathways genetically.","evidence":"Gab2/SHP2 conditional knockouts and Kit Y719F/Y567 compound mice; Plcg2-/- mice with U73122 inhibition in osteoclasts","pmids":["16873377","17053833"],"confidence":"High","gaps":["Direct PLCγ2-GAB2 binding interface not structurally defined","How distinct Kit tyrosines partition GAB2 effector output incompletely understood"]},{"year":2007,"claim":"Extended GAB2's oncogenic and signaling repertoire to ErbB2-driven metastasis, Stat3 activation in erythroleukemia, and suggested a neuronal role in tau regulation.","evidence":"Gab2-/- rescue in Neu metastasis model; Sf-Stk/Stat3 binding-site analysis in Friend erythroleukemia; siRNA and IHC in Alzheimer's brain","pmids":["17310989","17353274","16314834","17553421"],"confidence":"Medium","gaps":["Neuronal tau finding rests on a single siRNA experiment with indirect readout, not independently confirmed","Mechanism linking GAB2-ERK specifically to metastasis vs proliferation incomplete"]},{"year":2008,"claim":"Defined 14-3-3 binding at Ser210/Thr391 as a second negative-feedback module that uncouples GAB2 from GRB2/receptor, and refined receptor-coupling determinants and kinase inputs.","evidence":"Phosphoproteomics, S210A/T391A and constitutive-binding knock-in mutants with transformation assays; Lyn/c-Cbl Co-IP in imatinib-resistant CML; c-Kit splice-form PI3K comparison","pmids":["19172738","18235045","18697750"],"confidence":"High","gaps":["Integration of the multiple feedback loops (Ser159, 14-3-3, RSK) into a single regulatory model not addressed","In vivo relevance of 14-3-3 feedback to tumorigenesis untested"]},{"year":2009,"claim":"Provided structural basis for the GAB2-GRB2 interaction and extended GAB2's pro-metastatic and osteoclast scaffolding roles via PI3K-AKT and RANK-HCR-PLCγ2.","evidence":"Crystal structures of Gab2a/b-Grb2SH3C with ITC; GAB2 gain/loss-of-function in melanoma xenografts; RANK HCR domain mutants with NFATc1/NF-κB assays","pmids":["19523899","19342374","19845770"],"confidence":"High","gaps":["Full-length GAB2 structure and multivalent complex architecture unresolved","How two distinct GRB2-binding modes are used contextually unknown"]},{"year":2010,"claim":"Defined the mechanism by which GAB2 suppresses RhoA—SHP2-dependent Vav2 phosphorylation and p190A RhoGAP membrane recruitment—linking GAB2 to cytoskeletal remodeling and migration.","evidence":"GAB2 SHP2-binding mutants, RhoA/Rac-GTP pulldowns, constitutively active RhoA rescue and p190A knockdown","pmids":["21118992"],"confidence":"High","gaps":["Whether this RhoA-suppression axis operates in vivo during metastasis untested","Connection to earlier GC-GAP finding not reconciled"]},{"year":2011,"claim":"Genetic knock-in mice resolved the division of labor between GAB2's PI3K and SHP2 binding sites in mast-cell function (granule translocation vs degranulation) and defined an ARF1 effector arm, while linking GAB2-SHP2 to Lyn activation in G-CSF signaling and EMT in ovarian cancer.","evidence":"PI3K- and SHP2-binding-defective GAB2 knock-in mice with ARF1 assays/anaphylaxis; Shp2-dependent Lyn Tyr507 dephosphorylation assays; pathway-specific GAB2 mutants and Zeb1 knockdown in ovarian cancer","pmids":["21653832","21636860","21996746"],"confidence":"High","gaps":["Generalizability of site-specific functional partitioning across other receptors not established","Structural basis for effector selectivity unresolved"]},{"year":2012,"claim":"Identified GAB2 as a PKA anchoring protein, connecting cAMP-PKA signaling to the PI3K/AKT pathway and reinforcing Ser159 as a convergent regulatory site.","evidence":"Co-IP of PKA RI subunit with GAB2 and FSH-stimulated AKT assays in granulosa cells","pmids":["23045700"],"confidence":"Medium","gaps":["Single-lab Co-IP without reciprocal structural validation of the AKAP function","Functional consequence of AKAP activity in vivo untested"]},{"year":2013,"claim":"Established RSK as a third negative-feedback kinase that selectively blocks SHP2 recruitment to GAB2 without disrupting GRB2 binding, restraining the pro-invasive SHP2-ERK arm.","evidence":"In vitro RSK kinase assay, MS site mapping, mutagenesis, Co-IP, and motility assays","pmids":["23401857"],"confidence":"High","gaps":["Crosstalk between RSK, AKT, and 14-3-3 feedback loops not integrated","In vivo tumor relevance of RSK feedback untested"]},{"year":2015,"claim":"Demonstrated druggability of the 14-3-3/GAB2 interface by stabilizing it pharmacologically at the pThr391 site, validating the feedback complex as a therapeutic target.","evidence":"Crystal structure of ISIR-005/14-3-3/Gab2 with ITC","pmids":["26644359"],"confidence":"High","gaps":["Cellular and in vivo efficacy of interface stabilization not demonstrated","Selectivity over other 14-3-3 client interactions unknown"]},{"year":2016,"claim":"Genetic double-mutant models defined GAB2 as a required effector of oncogenic SHP2 (Ptpn11E76K) via PI3K/mTOR and dissected distinct PI3K- vs SHP2-site requirements for myeloid versus lymphoid BCR-ABL leukemogenesis.","evidence":"Ptpn11E76K/+/Gab2-/- mice with rapamycin; Gab2-/- CML/B-ALL models with domain-specific mutant rescue","pmids":["27840422","26773044"],"confidence":"High","gaps":["Why lymphoid transformation requires only the SHP2 arm mechanistically unexplained","Therapeutic targeting of GAB2 in these leukemias not tested clinically"]},{"year":2017,"claim":"Broadened GAB2's tumor and immune roles: it cooperates with MYCN via SHP2-RAS-ERK in neuroblastoma, lies downstream of YAP/TAZ feeding PI3K in endometrial cancer, and confers IL-4 signal preference (STAT6) for macrophage M2 polarization.","evidence":"Zebrafish MYCN/Gab2 model; YAP/TAZ knockdown with GAB2/PI3K readouts; Gab1/Gab2 knockouts with IL-4/STAT6 signaling and bleomycin fibrosis","pmids":["28329685","28202507","28687632"],"confidence":"Medium","gaps":["Direct vs indirect transcriptional regulation of GAB2 by YAP/TAZ not dissected","Mechanism of GAB2-specific STAT6 coupling unresolved"]},{"year":2022,"claim":"Defined a vascular role for GAB2 as a CBM-signalosome assembly scaffold mediating IL-1β-induced Rho/NF-κB signaling and thrombosis, extending GAB2 beyond hematopoietic and tumor contexts.","evidence":"Gab2/MALT1 knockdown, mepazine inhibition, CBM Co-IP, endothelial exocytosis assays, and IVC ligation thrombosis mouse models","pmids":["35895897"],"confidence":"High","gaps":["Direct GAB2 binding partner within the CBM complex not mapped","Whether canonical PI3K/SHP2 sites are required for CBM assembly untested"]},{"year":null,"claim":"How the multiple negative-feedback phosphorylation events (Ser159 by AKT/PKA, Ser210/Thr391 by 14-3-3, RSK sites) are integrated to set GAB2's quantitative signaling threshold, and how GAB2 selects between PI3K and SHP2 effector arms in a given receptor context, remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No unified structural model of full-length GAB2 in a receptor complex","Cross-regulation among feedback kinases not reconstituted","Determinants of PI3K vs SHP2 arm selection across receptors undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1,5,13,21]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[17,24,34,36]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[10,13]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8,10,13,34]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,3,13,21]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,8,13,45]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[20,26,32,41,42]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,19]}],"complexes":["CBM (CARMA3-BCL10-MALT1) signalosome","GAB2/SHP2/PI3K(p85)/GRB2 receptor complex","14-3-3/GAB2 complex"],"partners":["SHP2/PTPN11","PIK3R1/P85","GRB2","PLCG2","CRKL","LYN","STAT5","14-3-3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UQC2","full_name":"GRB2-associated-binding protein 2","aliases":["GRB2-associated binder 2","Growth factor receptor bound protein 2-associated protein 2","pp100"],"length_aa":676,"mass_kda":74.5,"function":"Adapter protein which acts downstream of several membrane receptors including cytokine, antigen, hormone, cell matrix and growth factor receptors to regulate multiple signaling pathways. Regulates osteoclast differentiation mediating the TNFRSF11A/RANK signaling. In allergic response, it plays a role in mast cells activation and degranulation through PI-3-kinase regulation. Also involved in the regulation of cell proliferation and hematopoiesis","subcellular_location":"Cytoplasm; Cell membrane; Membrane raft","url":"https://www.uniprot.org/uniprotkb/Q9UQC2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GAB2","classification":"Not Classified","n_dependent_lines":90,"n_total_lines":1208,"dependency_fraction":0.07450331125827815},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GAB2","total_profiled":1310},"omim":[{"mim_id":"621356","title":"SH3 AND CYSTEINE-RICH DOMAINS 2; STAC2","url":"https://www.omim.org/entry/621356"},{"mim_id":"620029","title":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, LANGUAGE DELAY, AND SKELETAL DEFECTS WITH OR WITHOUT SEIZURES; NEDHLSS","url":"https://www.omim.org/entry/620029"},{"mim_id":"618447","title":"LONG QT SYNDROME 8; LQT8","url":"https://www.omim.org/entry/618447"},{"mim_id":"611875","title":"BRUGADA SYNDROME 3; BRGDA3","url":"https://www.omim.org/entry/611875"},{"mim_id":"608360","title":"LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8A; LRRC8A","url":"https://www.omim.org/entry/608360"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":54.0}],"url":"https://www.proteinatlas.org/search/GAB2"},"hgnc":{"alias_symbol":["KIAA0571"],"prev_symbol":[]},"alphafold":{"accession":"Q9UQC2","domains":[{"cath_id":"2.30.29.30","chopping":"7-119","consensus_level":"high","plddt":83.6504,"start":7,"end":119}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UQC2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UQC2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UQC2-F1-predicted_aligned_error_v6.png","plddt_mean":51.91},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GAB2","jax_strain_url":"https://www.jax.org/strain/search?query=GAB2"},"sequence":{"accession":"Q9UQC2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UQC2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UQC2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UQC2"}},"corpus_meta":[{"pmid":"17553421","id":"PMC_17553421","title":"GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.","date":"2007","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/17553421","citation_count":372,"is_preprint":false},{"pmid":"12124177","id":"PMC_12124177","title":"Critical role for Gab2 in transformation by BCR/ABL.","date":"2002","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/12124177","citation_count":278,"is_preprint":false},{"pmid":"9885561","id":"PMC_9885561","title":"Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation.","date":"1998","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/9885561","citation_count":271,"is_preprint":false},{"pmid":"11449275","id":"PMC_11449275","title":"Essential role for Gab2 in the allergic response.","date":"2001","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/11449275","citation_count":255,"is_preprint":false},{"pmid":"16369543","id":"PMC_16369543","title":"A role for the scaffolding adapter GAB2 in breast cancer.","date":"2005","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16369543","citation_count":171,"is_preprint":false},{"pmid":"17053833","id":"PMC_17053833","title":"PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.","date":"2006","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17053833","citation_count":170,"is_preprint":false},{"pmid":"15750601","id":"PMC_15750601","title":"The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis.","date":"2005","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15750601","citation_count":138,"is_preprint":false},{"pmid":"23045700","id":"PMC_23045700","title":"PKA and GAB2 play central roles in the FSH signaling pathway to PI3K and AKT in ovarian granulosa cells.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23045700","citation_count":124,"is_preprint":false},{"pmid":"10391903","id":"PMC_10391903","title":"Gab2, a new pleckstrin homology domain-containing adapter protein, acts to uncouple signaling from ERK kinase to Elk-1.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10391903","citation_count":114,"is_preprint":false},{"pmid":"11861309","id":"PMC_11861309","title":"Requirement of Gab2 for mast cell development and KitL/c-Kit signaling.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11861309","citation_count":113,"is_preprint":false},{"pmid":"16253990","id":"PMC_16253990","title":"Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16253990","citation_count":99,"is_preprint":false},{"pmid":"15833084","id":"PMC_15833084","title":"Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15833084","citation_count":91,"is_preprint":false},{"pmid":"18235045","id":"PMC_18235045","title":"Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18235045","citation_count":90,"is_preprint":false},{"pmid":"16278304","id":"PMC_16278304","title":"Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML).","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16278304","citation_count":90,"is_preprint":false},{"pmid":"11027663","id":"PMC_11027663","title":"Flt3 ligand induces tyrosine phosphorylation of gab1 and gab2 and their association with shp-2, grb2, and PI3 kinase.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11027663","citation_count":90,"is_preprint":false},{"pmid":"12821647","id":"PMC_12821647","title":"Critical role for scaffolding adapter Gab2 in Fc gamma R-mediated phagocytosis.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12821647","citation_count":89,"is_preprint":false},{"pmid":"22871571","id":"PMC_22871571","title":"GAB2--a scaffolding protein in cancer.","date":"2012","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/22871571","citation_count":84,"is_preprint":false},{"pmid":"10455108","id":"PMC_10455108","title":"Engagement of Gab1 and Gab2 in erythropoietin signaling.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10455108","citation_count":84,"is_preprint":false},{"pmid":"12140767","id":"PMC_12140767","title":"The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12140767","citation_count":78,"is_preprint":false},{"pmid":"17310989","id":"PMC_17310989","title":"Role of Gab2 in mammary tumorigenesis and metastasis.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17310989","citation_count":75,"is_preprint":false},{"pmid":"11287610","id":"PMC_11287610","title":"Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptor tyrosine kinase.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11287610","citation_count":74,"is_preprint":false},{"pmid":"10849428","id":"PMC_10849428","title":"The docking molecule gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common gamma chain-using cytokines.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10849428","citation_count":71,"is_preprint":false},{"pmid":"11782427","id":"PMC_11782427","title":"PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11782427","citation_count":71,"is_preprint":false},{"pmid":"19342374","id":"PMC_19342374","title":"Gab2-mediated signaling promotes melanoma metastasis.","date":"2009","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19342374","citation_count":69,"is_preprint":false},{"pmid":"19523899","id":"PMC_19523899","title":"Distinct binding modes of two epitopes in Gab2 that interact with the SH3C domain of Grb2.","date":"2009","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/19523899","citation_count":68,"is_preprint":false},{"pmid":"11572860","id":"PMC_11572860","title":"Docking protein Gab2 is phosphorylated by ZAP-70 and negatively regulates T cell receptor signaling by recruitment of inhibitory molecules.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11572860","citation_count":67,"is_preprint":false},{"pmid":"16873377","id":"PMC_16873377","title":"The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16873377","citation_count":67,"is_preprint":false},{"pmid":"21996746","id":"PMC_21996746","title":"Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21996746","citation_count":66,"is_preprint":false},{"pmid":"15952937","id":"PMC_15952937","title":"Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15952937","citation_count":64,"is_preprint":false},{"pmid":"26095858","id":"PMC_26095858","title":"Structure and function of Gab2 and its role in cancer (Review).","date":"2015","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/26095858","citation_count":61,"is_preprint":false},{"pmid":"26754532","id":"PMC_26754532","title":"Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.","date":"2016","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/26754532","citation_count":61,"is_preprint":false},{"pmid":"19881546","id":"PMC_19881546","title":"Focal amplification and oncogene dependency of GAB2 in breast cancer.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19881546","citation_count":60,"is_preprint":false},{"pmid":"11830491","id":"PMC_11830491","title":"Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11830491","citation_count":59,"is_preprint":false},{"pmid":"15010462","id":"PMC_15010462","title":"Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15010462","citation_count":59,"is_preprint":false},{"pmid":"26657155","id":"PMC_26657155","title":"Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26657155","citation_count":56,"is_preprint":false},{"pmid":"26644359","id":"PMC_26644359","title":"Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface.","date":"2015","source":"ChemMedChem","url":"https://pubmed.ncbi.nlm.nih.gov/26644359","citation_count":55,"is_preprint":false},{"pmid":"11035047","id":"PMC_11035047","title":"Cutting edge: gab2 mediates an inhibitory phosphatidylinositol 3'-kinase pathway in T cell antigen receptor signaling.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11035047","citation_count":54,"is_preprint":false},{"pmid":"28687632","id":"PMC_28687632","title":"Increased levels of Gab1 and Gab2 adaptor proteins skew interleukin-4 (IL-4) signaling toward M2 macrophage-driven pulmonary fibrosis in mice.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28687632","citation_count":53,"is_preprint":false},{"pmid":"19172738","id":"PMC_19172738","title":"Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein.","date":"2008","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19172738","citation_count":51,"is_preprint":false},{"pmid":"12058075","id":"PMC_12058075","title":"Distinct recruitment and function of Gab1 and Gab2 in Met receptor-mediated epithelial morphogenesis.","date":"2002","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12058075","citation_count":50,"is_preprint":false},{"pmid":"19509136","id":"PMC_19509136","title":"GAB2 amplifications refine molecular classification of melanoma.","date":"2009","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/19509136","citation_count":50,"is_preprint":false},{"pmid":"27840422","id":"PMC_27840422","title":"Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations.","date":"2016","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/27840422","citation_count":49,"is_preprint":false},{"pmid":"22858987","id":"PMC_22858987","title":"Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors.","date":"2012","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/22858987","citation_count":48,"is_preprint":false},{"pmid":"18697750","id":"PMC_18697750","title":"Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18697750","citation_count":48,"is_preprint":false},{"pmid":"28202507","id":"PMC_28202507","title":"YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/28202507","citation_count":47,"is_preprint":false},{"pmid":"14656892","id":"PMC_14656892","title":"G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/14656892","citation_count":46,"is_preprint":false},{"pmid":"12640133","id":"PMC_12640133","title":"Gads/Grb2-mediated association with LAT is critical for the inhibitory function of Gab2 in T cells.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12640133","citation_count":46,"is_preprint":false},{"pmid":"16736498","id":"PMC_16736498","title":"GAB2 is a novel target of 11q amplification in AML/MDS.","date":"2006","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16736498","citation_count":44,"is_preprint":false},{"pmid":"11895767","id":"PMC_11895767","title":"Role of the docking protein Gab2 in beta(1)-integrin signaling pathway-mediated hematopoietic cell adhesion and migration.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11895767","citation_count":44,"is_preprint":false},{"pmid":"35577506","id":"PMC_35577506","title":"Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway.","date":"2022","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35577506","citation_count":43,"is_preprint":false},{"pmid":"12819203","id":"PMC_12819203","title":"GC-GAP, a Rho family GTPase-activating protein that interacts with signaling adapters Gab1 and Gab2.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12819203","citation_count":42,"is_preprint":false},{"pmid":"11334882","id":"PMC_11334882","title":"A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners.","date":"2001","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11334882","citation_count":42,"is_preprint":false},{"pmid":"17374739","id":"PMC_17374739","title":"Abnormal hematopoiesis in Gab2 mutant mice.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17374739","citation_count":41,"is_preprint":false},{"pmid":"16009726","id":"PMC_16009726","title":"A novel role for Gab2 in bFGF-mediated cell survival during retinoic acid-induced neuronal differentiation.","date":"2005","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16009726","citation_count":40,"is_preprint":false},{"pmid":"11335710","id":"PMC_11335710","title":"Phosphoinositide 3-kinase-dependent regulation of interleukin-3-induced proliferation: involvement of mitogen-activated protein kinases, SHP2 and Gab2.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11335710","citation_count":40,"is_preprint":false},{"pmid":"30755611","id":"PMC_30755611","title":"Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30755611","citation_count":39,"is_preprint":false},{"pmid":"35895897","id":"PMC_35895897","title":"The Gab2-MALT1 axis regulates thromboinflammation and deep vein thrombosis.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/35895897","citation_count":38,"is_preprint":false},{"pmid":"17558859","id":"PMC_17558859","title":"Increased expression of Gab2, a scaffolding adaptor of the tyrosine kinase signalling, in gastric carcinomas.","date":"2007","source":"Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17558859","citation_count":38,"is_preprint":false},{"pmid":"29326440","id":"PMC_29326440","title":"BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29326440","citation_count":38,"is_preprint":false},{"pmid":"17998934","id":"PMC_17998934","title":"Gab2 and Src co-operate in human mammary epithelial cells to promote growth factor independence and disruption of acinar morphogenesis.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17998934","citation_count":38,"is_preprint":false},{"pmid":"24385586","id":"PMC_24385586","title":"In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24385586","citation_count":37,"is_preprint":false},{"pmid":"28420432","id":"PMC_28420432","title":"Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.","date":"2017","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/28420432","citation_count":36,"is_preprint":false},{"pmid":"19233262","id":"PMC_19233262","title":"Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells.","date":"2009","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/19233262","citation_count":36,"is_preprint":false},{"pmid":"11971018","id":"PMC_11971018","title":"The adapter molecule Gab2 regulates Fc epsilon RI-mediated signal transduction in mast cells.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11971018","citation_count":36,"is_preprint":false},{"pmid":"26611835","id":"PMC_26611835","title":"Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1.","date":"2015","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/26611835","citation_count":35,"is_preprint":false},{"pmid":"21653832","id":"PMC_21653832","title":"Gab2, via PI-3K, regulates ARF1 in FcεRI-mediated granule translocation and mast cell degranulation.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21653832","citation_count":35,"is_preprint":false},{"pmid":"20335178","id":"PMC_20335178","title":"The limited contribution of Fyn and Gab2 to the high affinity IgE receptor signaling in mast cells.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20335178","citation_count":34,"is_preprint":false},{"pmid":"12464621","id":"PMC_12464621","title":"Epidermal growth factor-induced DNA synthesis. Key role for Src phosphorylation of the docking protein Gab2.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12464621","citation_count":33,"is_preprint":false},{"pmid":"19204163","id":"PMC_19204163","title":"GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results.","date":"2009","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19204163","citation_count":32,"is_preprint":false},{"pmid":"23231021","id":"PMC_23231021","title":"Gab2 expression in glioma and its implications for tumor invasion.","date":"2012","source":"Acta oncologica (Stockholm, Sweden)","url":"https://pubmed.ncbi.nlm.nih.gov/23231021","citation_count":31,"is_preprint":false},{"pmid":"21636860","id":"PMC_21636860","title":"G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21636860","citation_count":31,"is_preprint":false},{"pmid":"15170389","id":"PMC_15170389","title":"Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15170389","citation_count":31,"is_preprint":false},{"pmid":"18272374","id":"PMC_18272374","title":"Association study of the GAB2 gene with the risk of developing Alzheimer's disease.","date":"2008","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/18272374","citation_count":31,"is_preprint":false},{"pmid":"19118819","id":"PMC_19118819","title":"The GAB2 gene and the risk of Alzheimer's disease: replication and meta-analysis.","date":"2008","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19118819","citation_count":30,"is_preprint":false},{"pmid":"10991949","id":"PMC_10991949","title":"Recruitment of the protein-tyrosine phosphatase SHP-2 to the C-terminal tyrosine of the prolactin receptor and to the adaptor protein Gab2.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10991949","citation_count":30,"is_preprint":false},{"pmid":"28329685","id":"PMC_28329685","title":"Critical Role for GAB2 in Neuroblastoma Pathogenesis through the Promotion of SHP2/MYCN Cooperation.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28329685","citation_count":29,"is_preprint":false},{"pmid":"28295819","id":"PMC_28295819","title":"Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children's oncology group.","date":"2017","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28295819","citation_count":29,"is_preprint":false},{"pmid":"23401857","id":"PMC_23401857","title":"Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23401857","citation_count":28,"is_preprint":false},{"pmid":"31194976","id":"PMC_31194976","title":"Gab2 promotes cancer stem cell like properties and metastatic growth of ovarian cancer via downregulation of miR-200c.","date":"2019","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31194976","citation_count":28,"is_preprint":false},{"pmid":"17353274","id":"PMC_17353274","title":"A novel Stat3 binding motif in Gab2 mediates transformation of primary hematopoietic cells by the Stk/Ron receptor tyrosine kinase in response to Friend virus infection.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353274","citation_count":28,"is_preprint":false},{"pmid":"19845770","id":"PMC_19845770","title":"A unique domain in RANK is required for Gab2 and PLCgamma2 binding to establish osteoclastogenic signals.","date":"2009","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/19845770","citation_count":27,"is_preprint":false},{"pmid":"22926523","id":"PMC_22926523","title":"GAB2 induces tumor angiogenesis in NRAS-driven melanoma.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22926523","citation_count":26,"is_preprint":false},{"pmid":"30127957","id":"PMC_30127957","title":"miR-486-5p inhibits cell proliferation and invasion through repressing GAB2 in non-small cell lung cancer.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/30127957","citation_count":26,"is_preprint":false},{"pmid":"19438505","id":"PMC_19438505","title":"A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival.","date":"2009","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/19438505","citation_count":26,"is_preprint":false},{"pmid":"28842424","id":"PMC_28842424","title":"Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28842424","citation_count":25,"is_preprint":false},{"pmid":"16314834","id":"PMC_16314834","title":"GRB2-mediated recruitment of GAB2, but not GAB1, to SF-STK supports the expansion of Friend virus-infected erythroid progenitor cells.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16314834","citation_count":25,"is_preprint":false},{"pmid":"18853460","id":"PMC_18853460","title":"Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia.","date":"2009","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/18853460","citation_count":25,"is_preprint":false},{"pmid":"20087860","id":"PMC_20087860","title":"Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development.","date":"2010","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20087860","citation_count":25,"is_preprint":false},{"pmid":"20502503","id":"PMC_20502503","title":"The Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer's disease.","date":"2010","source":"Neuroscience bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/20502503","citation_count":24,"is_preprint":false},{"pmid":"22851227","id":"PMC_22851227","title":"Participation of Gab1 and Gab2 in IL-22-mediated keratinocyte proliferation, migration, and differentiation.","date":"2012","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22851227","citation_count":24,"is_preprint":false},{"pmid":"25852062","id":"PMC_25852062","title":"Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition.","date":"2015","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25852062","citation_count":24,"is_preprint":false},{"pmid":"27026230","id":"PMC_27026230","title":"GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27026230","citation_count":23,"is_preprint":false},{"pmid":"19262956","id":"PMC_19262956","title":"GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.","date":"2009","source":"The journal of nutrition, health & aging","url":"https://pubmed.ncbi.nlm.nih.gov/19262956","citation_count":23,"is_preprint":false},{"pmid":"26773044","id":"PMC_26773044","title":"Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1.","date":"2016","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/26773044","citation_count":22,"is_preprint":false},{"pmid":"32522441","id":"PMC_32522441","title":"The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer.","date":"2020","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32522441","citation_count":22,"is_preprint":false},{"pmid":"28412750","id":"PMC_28412750","title":"microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2).","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28412750","citation_count":22,"is_preprint":false},{"pmid":"18644434","id":"PMC_18644434","title":"G-CSF stimulates Jak2-dependent Gab2 phosphorylation leading to Erk1/2 activation and cell proliferation.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18644434","citation_count":22,"is_preprint":false},{"pmid":"34726254","id":"PMC_34726254","title":"Role of microRNA‑218‑5p in sevoflurane‑induced protective effects in hepatic ischemia/reperfusion injury mice by regulating GAB2/PI3K/AKT pathway.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/34726254","citation_count":22,"is_preprint":false},{"pmid":"18854865","id":"PMC_18854865","title":"GAB2 is not associated with late-onset Alzheimer's disease in Japanese.","date":"2008","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/18854865","citation_count":22,"is_preprint":false},{"pmid":"21118992","id":"PMC_21118992","title":"Gab2 regulates cytoskeletal organization and migration of mammary epithelial cells by modulating RhoA activation.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21118992","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52643,"output_tokens":12212,"usd":0.170554,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23449,"output_tokens":7204,"usd":0.148673,"stage2_stop_reason":"end_turn"},"total_usd":0.319227,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"GAB2 (p97) was cloned and identified as a scaffolding protein that, upon cytokine/growth factor/antigen receptor stimulation, becomes tyrosyl phosphorylated and associates with SHP2 and other SH2 domain-containing proteins. Expression of p97 mutants unable to bind SHP2 blocks cytokine-induced c-fos promoter activation, inhibiting Elk1-mediated and STAT5-mediated transactivation without inhibiting MAPK activation, revealing a novel pathway to immediate-early gene activation.\",\n      \"method\": \"Cloning, co-immunoprecipitation, dominant-negative mutant expression, reporter gene assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, dominant-negative mutants, reporter assays) in the foundational characterization paper\",\n      \"pmids\": [\"9885561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"GAB2 contains an N-terminal pleckstrin homology (PH) domain and upon tyrosine phosphorylation physically interacts with SHP2 and GRB2. GAB2 has an inhibitory effect on Elk-1-dependent transcription triggered by dominant-active Ras or growth factor stimulation, while having a similar function to GAB1 in ERK activation, demonstrating uncoupling of ERK and Elk-1 signaling.\",\n      \"method\": \"Co-immunoprecipitation, reporter gene assays (Elk-1, SRE), dominant-active Ras overexpression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP plus functional reporter assays with multiple mutants, foundational paper\",\n      \"pmids\": [\"10391903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GAB2 is essential for mast cell allergic responses: Gab2-/- mice show defective FcεRI-induced degranulation and cytokine gene expression. GAB2 is the principal activator of PI3K downstream of FcεRI, as PI3K-dependent signaling pathways are defective in Gab2-/- mast cells.\",\n      \"method\": \"Gab2 knockout mice, mast cell functional assays (degranulation, cytokine production), passive cutaneous and systemic anaphylaxis models, biochemical pathway analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with multiple orthogonal phenotypic and biochemical readouts, replicated in vivo\",\n      \"pmids\": [\"11449275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BCR-ABL recruits GAB2 via a GRB2/GAB2 complex through BCR-ABL Tyr177. GAB2 tyrosine phosphorylation enables association of PI3K and SHP2 with GAB2/BCR-ABL, activating PI3K/AKT and RAS/ERK pathways. Gab2-/- bone marrow myeloid progenitors are resistant to BCR-ABL transformation; lymphoid transformation is diminished with increased apoptosis.\",\n      \"method\": \"Gab2 knockout mice, BCR-ABL Y177F mutant, co-immunoprecipitation, bone marrow transformation assays, proliferation/migration assays\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout combined with BCR-ABL point mutant and Co-IP, multiple orthogonal methods\",\n      \"pmids\": [\"12124177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GAB2 is required for mast cell development and KitL/c-Kit signaling. Gab2-deficient mice show markedly reduced mast cell numbers, and Gab2-deficient BMMCs show impaired KitL-induced ERK and AKT activation.\",\n      \"method\": \"Gab2 knockout mice, bone marrow-derived mast cell cultures, ERK/AKT phosphorylation assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with multiple signaling readouts and in vivo phenotype\",\n      \"pmids\": [\"11861309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GAB2 acts as a scaffolding adapter downstream of the M-CSF receptor Fms: it associates with GRB2, SHP2, p85/PI3K, SHIP, and SHC upon M-CSF stimulation. GAB2 overexpression enhanced MAPK activity and macrophage differentiation; a SHP2-binding-defective mutant inhibited differentiation and increased proliferation, demonstrating that GAB2-SHP2 interaction is essential for M-CSF-induced differentiation signaling.\",\n      \"method\": \"Co-immunoprecipitation, GAB2 overexpression and dominant-negative mutants, MAPK assays, differentiation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — structure-function with multiple mutants and orthogonal functional readouts\",\n      \"pmids\": [\"11287610\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GAB2 regulates beta1-integrin signaling in hematopoietic cells: beta1 integrin cross-linking induces tyrosine phosphorylation of GAB2 and its association with Syk kinase, SHP-2, and PI3K p85. Overexpression of PH domain or SHP-2 binding-defective GAB2 mutants reduced cell adhesion, migration, and beta1-integrin-induced PI3K activation.\",\n      \"method\": \"Co-immunoprecipitation, GAB2 mutant overexpression, adhesion and migration assays, PI3K activity assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus functional assays, single lab, multiple methods\",\n      \"pmids\": [\"11895767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GAB2 is a docking protein for SHP2 and PI3K downstream of the IL-2 receptor: phosphorylation of GAB2 depends on JAK3 (not Lck or Syk) and requires Tyr338 of the IL-2 receptor beta chain. GAB2 is the major SHP-2 and PI3K-associated 98-kDa protein in IL-2-activated lymphocytes; only IL-2 and IL-15 (not other gamma-c cytokines) induce GAB2 phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation, IL-2 receptor mutants, JAK3 inhibition/knockout studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including receptor mutants and kinase-specific inhibitors/knockouts\",\n      \"pmids\": [\"10849428\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GAB2 is phosphorylated by ZAP-70 in T cells and negatively regulates TCR signaling. GAB2 co-precipitates with ZAP-70, LAT, and CD3ζ upon TCR stimulation. Overexpression inhibits NF-AT activation and IL-2 production; inhibitory function requires SHP-2 binding sites and PI3K binding capacity. The PH domain is required for plasma membrane localization.\",\n      \"method\": \"Co-immunoprecipitation, GAB2 overexpression in Jurkat cells and T cell hybridomas, NF-AT reporter assays, GAB2 mutant analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple mutants combined with functional and localization readouts in two T cell systems\",\n      \"pmids\": [\"11572860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PKB/AKT constitutively associates with GAB2 and phosphorylates GAB2 on Ser159, providing negative feedback: Ser159 phosphorylation inhibits GAB2 tyrosine phosphorylation. Gab2-S159A mutant enhances HRG-induced tyrosine phosphorylation, amplifies ERK and PKB pathway activation, increases ErbB2 tyrosine phosphorylation, and has potent transforming activity in fibroblasts, establishing GAB2 as a proto-oncogene.\",\n      \"method\": \"In vitro kinase assay (PKB phosphorylation of GAB2 at Ser159), site-directed mutagenesis (S159A), co-immunoprecipitation, focus-forming assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay plus mutagenesis plus functional transformation assay, multiple orthogonal methods\",\n      \"pmids\": [\"11782427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GAB2 mediates a negative regulatory role in FcεRI signaling in mast cells: upon FcεRI aggregation, GAB2 translocates from cytosol to plasma membrane and associates with SHP2, GRB2, Lyn, and PLCγ. Overexpression of GAB2 inhibited FcεRI-induced phosphorylation of Syk and MAPK, calcium mobilization, degranulation, and TNF-α/IL-6 gene expression, while leaving Akt phosphorylation unaffected.\",\n      \"method\": \"Co-immunoprecipitation, GAB2 overexpression in RBL-2H3 cells, calcium mobilization assay, degranulation assay, cytokine mRNA analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus multiple functional readouts, single lab\",\n      \"pmids\": [\"11971018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GAB2 interacts with SHP-2 via specific tyrosines: Y452, Y476, and Y584 mediate p85-PI3K binding; Y614 exclusively mediates SHP-2 binding; Y266 and Y293 mediate CrkL binding (via CrkL SH2). These interactions were mapped using a yeast two-hybrid system with Lyn kinase co-expression.\",\n      \"method\": \"Modified yeast two-hybrid with Lyn tyrosine kinase co-expression, tyrosine mutants\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic mutant mapping in yeast two-hybrid system, single lab\",\n      \"pmids\": [\"11334882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"In BCR-ABL+ K562 CML cells, GAB2 overexpression selectively activates the Erk2-Elk1 signaling pathway in a manner dependent on GAB2 Tyr604 (SHP2 docking site) and SHP2 phosphatase activity. Induced GAB2 expression promotes Erk activation, growth arrest, and megakaryocytic differentiation.\",\n      \"method\": \"Erk2-Elk1 reporter assays, inducible Gab2 expression, GAB2 Y604F mutant analysis, differentiation markers\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — structure-function with specific point mutants and multiple functional readouts, single lab\",\n      \"pmids\": [\"11830491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GAB2 is required for FcγR-mediated phagocytosis in macrophages: upon FcγR activation, GAB2 becomes tyrosyl phosphorylated, associates with PI3K p85 and SHP2, and is recruited to the nascent phagosome where PI3K lipid production occurs. Gab2-/- macrophages show severely impaired FcγR phagocytosis correlating with decreased Akt activation. PH domain and GRB2-binding site of GAB2 are required for phagosome recruitment, and phagosome localization is sensitive to PI3K inhibition.\",\n      \"method\": \"Gab2 knockout mice, confocal fluorescence microscopy, co-immunoprecipitation, phagocytosis assays, wortmannin treatment, GAB2 mutant analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout plus live imaging and mutant analysis with multiple orthogonal readouts\",\n      \"pmids\": [\"12821647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GAB2 interacts with GC-GAP, a RhoA/Rac1/Cdc42 GTPase-activating protein, through its middle region. This interaction was identified by yeast two-hybrid screening and GC-GAP reduces active Rac1 and Cdc42 levels, suggesting GAB2 may regulate Rho family GTPase activity through GC-GAP recruitment.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, in vitro GAP activity assay, siRNA knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus in vitro GAP assay, single lab\",\n      \"pmids\": [\"12819203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GAB2 inhibitory function in T cells requires Gads/Grb2-mediated association with LAT. The MBD domain of GAB2 contains a PXXXR motif that is critical for constitutive association with Gads/Grb2, which recruits GAB2 to lipid rafts after TCR ligation. Gab2-deficient T cells show enhanced proliferative responses to TCR stimulation.\",\n      \"method\": \"Gab2 knockout mice, GAB2 mutant analysis, co-immunoprecipitation, lipid raft fractionation, T cell transgenic mice\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout plus transgenic mice plus mutant analysis with multiple functional readouts\",\n      \"pmids\": [\"12640133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In T cells, GAB2 delivers an inhibitory signal via PI3K: overexpression of GAB2 inhibits TCR-evoked IL-2 promoter activation (blocking NF-AT and NF-κB transcription). Inhibition is abrogated by mutating GAB2 p85-binding sites or by PI3K inhibitor treatment.\",\n      \"method\": \"GAB2 overexpression in T cell lines, reporter gene assays (IL-2 promoter, NF-AT, NF-κB), PI3K inhibitors, GAB2 p85-binding site mutants\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — structure-function with mutants and pharmacological inhibitors, single lab\",\n      \"pmids\": [\"11035047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SHP2 binds GAB2 at Tyr614 via its N-terminal SH2 domain (and Tyr643 via C-terminal SH2, though Y614F mutation alone prevents SHP2 recruitment). This SHP2-GAB2 interaction is required for ERK activation and c-fos SRE transcriptional induction in response to IL-2. GAB2/SHP2-mediated ERK activation and Rho-dependent signals cooperate for full SRE induction.\",\n      \"method\": \"Co-immunoprecipitation with Tyr→Phe mutants, ERK activation assays, SRE reporter assays, dominant-active/dominant-negative RhoA\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-directed mutagenesis combined with functional reporter assays, single lab\",\n      \"pmids\": [\"15170389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Hematopoietic cell kinase (Hck) phosphorylates GAB1 and GAB2 in response to IL-6, and this Src-family kinase-dependent phosphorylation is required for IL-6-induced ERK and AKT activation and multiple myeloma cell proliferation/survival.\",\n      \"method\": \"Src family kinase inhibitor PP2, kinase-inactive Hck mutants, kinase assays, proliferation/survival assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase-inactive mutants plus pharmacological inhibition with functional readouts, single lab\",\n      \"pmids\": [\"15010462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GAB2 is the principal scaffold for RANK-induced NF-κB, Akt, and Jnk activation in osteoclastogenesis. Gab2-/- mice develop osteopetrosis with defective osteoclast differentiation. GAB2 associates with RANK and mediates RANK signaling to these downstream pathways.\",\n      \"method\": \"Gab2 knockout mice (osteopetrosis phenotype), co-immunoprecipitation with RANK, osteoclast differentiation assays, NF-κB/Akt/Jnk signaling assays\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with in vivo bone phenotype plus Co-IP and signaling assays, multiple orthogonal methods\",\n      \"pmids\": [\"15750601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In breast cancer, GAB2 overexpression increases proliferation and invasion of mammary epithelial cells; invasive phenotype with HER2 (Neu) is mediated by hyperactivation of the SHP2-ERK pathway. Gab2 deficiency ameliorates Neu-evoked breast carcinogenesis in mice.\",\n      \"method\": \"3D Matrigel culture, co-expression with Neu, Gab2 knockout in Neu-transgenic mouse model, signaling pathway analysis\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO in mouse cancer model plus 3D culture functional assays plus signaling, multiple orthogonal methods\",\n      \"pmids\": [\"16369543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GAB2 overexpression in MCF-10A cells enhances EGF-induced ERK and AKT activation, increases acinar size in 3D culture dependent on GRB2 and SHP2 binding, and overcomes EGF dependence. A GAB2 mutant unable to bind p85/PI3K has reduced effect on acinar size. These effects establish GAB2 as an amplifier of RTK signaling.\",\n      \"method\": \"3D Matrigel morphogenesis assay, GAB2 mutants (Grb2 binding, Shp2 binding, p85 binding), pharmacological MEK inhibition, signaling assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — structure-function with multiple domain-specific mutants and 3D functional assays, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16253990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Activated STAT5 promotes constitutive GAB2 tyrosine phosphorylation independent of JAK2, and GAB2 forms a complex with STAT5, p85/PI3K, and GRB2 (but not SHP2) in this context. A GAB2 mutant lacking PI3K binding sites (3YF) inhibits caSTAT5-induced proliferation, survival, and ERK/AKT activation, establishing GAB2 as essential for STAT5-driven PI3K/Akt and Ras/MAPK signaling.\",\n      \"method\": \"Co-immunoprecipitation, GAB2-3YF mutant overexpression, constitutively active STAT5 expression, proliferation/survival assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus functional mutant analysis, single lab\",\n      \"pmids\": [\"15833084\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PLCγ2 forms a complex with GAB2 in osteoclasts, is required for RANKL-mediated phosphorylation of GAB2, and modulates GAB2 recruitment to RANK. PLCγ2-dependent NFATc1 upregulation (but not JNK and NF-κB) requires Dap12/FcRγ receptors and is blocked by PLCγ inhibitor. PLCγ2 deletion results in osteopetrosis.\",\n      \"method\": \"Plcg2 knockout mice, co-immunoprecipitation, PLCγ inhibitor U73122, osteoclast differentiation assays, NFATc1 activation assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout plus Co-IP plus pharmacological inhibition with multiple signaling readouts\",\n      \"pmids\": [\"17053833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GAB2 requires SHP2 to activate the Rac/JNK pathway downstream of Kit Tyr567 in mast cells for SCF-evoked proliferation. GAB2 becomes tyrosyl-phosphorylated and associates with Kit and SHP2 upon Kit activation. SFK activity (via Tyr567) is required for GAB2 tyrosyl phosphorylation and SHP2 association. GAB2 acts in a parallel pathway to PI3K from Kit Tyr719.\",\n      \"method\": \"Gab2-/- mast cells, Gab2/SHP2 double conditional knockouts, compound Gab2-/-:KitY719F/Y719F mice, GAB2 mutants (SHP2-binding defective), JNK/Rac activation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models plus structure-function mutants plus rescue experiments\",\n      \"pmids\": [\"16873377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GAB2 knockdown increases tau phosphorylation in neurons, suggesting GAB2 negatively regulates tau phosphorylation. GAB2 protein is detected in neurons, tangle-bearing neurons, and dystrophic neurites in Alzheimer's disease brain.\",\n      \"method\": \"siRNA knockdown of GAB2, immunohistochemistry/immunofluorescence in human brain tissue\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single siRNA experiment with indirect tau phosphorylation readout, single lab\",\n      \"pmids\": [\"17553421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GAB2 is required for mammary tumor metastasis downstream of Neu/ErbB2: Gab2-/- cancer cells show decreased migration and impaired ERK activation; defects are rescued by re-introduction of Gab2. Gab2 ablation severely suppresses lung metastasis with normal Akt activity, indicating a specific role for GAB2-ERK in metastasis.\",\n      \"method\": \"Gab2 knockout in Neu-transgenic mouse breast cancer model, GAB2 re-expression rescue, migration assays, ERK/AKT signaling assays, lung metastasis quantification\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout in mouse cancer model plus rescue experiment plus multiple signaling readouts\",\n      \"pmids\": [\"17310989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"A novel Stat3 binding site in Gab2 mediates activation of Stat3 by Sf-Stk receptor tyrosine kinase (Friend virus-associated). Grb2-mediated recruitment of GAB2 (but not GAB1) to Sf-Stk supports expansion of infected erythroid progenitors. Gab2-/- mice are less susceptible to Friend erythroleukemia.\",\n      \"method\": \"Gab2 knockout mice, Sf-Stk/Gab2 fusion proteins, Stat3 reporter assays, co-immunoprecipitation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus novel binding site identification with functional assays, single lab\",\n      \"pmids\": [\"17353274\", \"16314834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"14-3-3 proteins bind GAB2 at growth factor-induced phosphorylation sites Ser210 and Thr391, providing negative feedback. The Gab2-S210A/T391A double mutant shows sustained receptor association and signaling and promotes cell proliferation and transformation. Introduction of constitutive 14-3-3 binding sites into GAB2 renders it refractory to receptor activation. 14-3-3 binding reduces Grb2 association, uncoupling GAB2 from the receptor complex.\",\n      \"method\": \"Mass spectrometry phosphoproteomics, site-directed mutagenesis (S210A/T391A), constitutive 14-3-3 binding site knock-in, co-immunoprecipitation, proliferation/transformation assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — phosphoproteomics plus mutagenesis plus functional transformation assays, multiple orthogonal methods\",\n      \"pmids\": [\"19172738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Lyn kinase (BCR-ABL-independent) forms a complex with GAB2 and c-Cbl in imatinib-resistant CML cells and mediates persistent GAB2 and BCR-ABL tyrosine phosphorylation. Lyn silencing or inhibition is required to suppress GAB2 phosphorylation and recover imatinib sensitivity.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, Lyn kinase inhibitors, imatinib sensitivity assays in CML cells and patient samples\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus siRNA knockdown plus pharmacological inhibition, single lab\",\n      \"pmids\": [\"18235045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GAB2 is involved in differential PI3K signaling by two splice forms of c-Kit (GNNK- vs GNNK+): GNNK- c-Kit mediates stronger PI3K/AKT activation dependent on GAB2 association. Src-mediated phosphorylation of GAB2 is independent of direct PI3K association with c-Kit. siRNA knockdown of GAB2 confirms its role in c-Kit-induced PI3K/AKT activation.\",\n      \"method\": \"siRNA knockdown of Gab2, c-Kit splice variant expression, co-immunoprecipitation, PI3K/AKT activation assays, Src inhibitor studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA plus Co-IP plus splice variant comparison, single lab\",\n      \"pmids\": [\"18697750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Two distinct epitopes in GAB2 (Gab2a and Gab2b) bind the Grb2 SH3C domain with different binding modes. Crystal structures reveal that Gab2b contains a 3(10) helix positioning an RxxK motif, while Gab2a contains the RxxK motif in a PPII helix. These define the molecular basis of GAB2-GRB2 interaction.\",\n      \"method\": \"Crystal structures of Gab2a/Grb2SH3C and Gab2b/Grb2SH3C complexes, isothermal titration calorimetry, peptide arrays\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures combined with ITC quantification, rigorous structural and biochemical validation\",\n      \"pmids\": [\"19523899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GAB2-mediated signaling promotes melanoma metastasis via PI3K-AKT hyperactivation. GAB2 overexpression potentiates migration and invasion; knockdown reduces them. PI3K-AKT pathway inhibition decreases GAB2-mediated tumor cell migration. GAB2 overexpression enhances in vivo tumor growth and metastasis.\",\n      \"method\": \"GAB2 siRNA knockdown, GAB2 overexpression, PI3K inhibitor treatment, in vitro migration/invasion assays, in vivo xenograft model\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function and gain-of-function with in vivo validation, single lab\",\n      \"pmids\": [\"19342374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RANK contains a highly conserved domain (HCR) that recruits GAB2, which then associates with PLCγ2, mediating sustained NF-κB activation and PLCγ2/NFATc1 activation during late-phase RANK signaling essential for osteoclastogenesis.\",\n      \"method\": \"Co-immunoprecipitation with RANK HCR domain mutants, RANK-deletion constructs, NF-κB and NFATc1 reporter assays, osteoclast differentiation\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mutant analysis plus Co-IP plus functional signaling assays, single lab\",\n      \"pmids\": [\"19845770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GAB2 suppresses RhoA activation via SHP2-dependent promotion of Vav2 phosphorylation and p190A RhoGAP plasma membrane recruitment. GAB2 overexpression decreases stress fibers and focal adhesions and enhances migration; effects are reversed by constitutively active RhoA or p190A RhoGAP knockdown. Both SHP2 binding sites in GAB2 are required for these effects.\",\n      \"method\": \"GAB2 overexpression, GAB2 mutants (SHP2-binding site mutations), RhoA/Rac-GTP pull-down assays, constitutively active RhoA rescue, p190A RhoGAP knockdown, cell morphology/migration assays\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — structure-function mutants plus RhoA/Rac activity assays plus multiple rescue experiments, multiple orthogonal methods\",\n      \"pmids\": [\"21118992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GAB2 via PI3K regulates ARF1 activation downstream of FcεRI for granule translocation in mast cell degranulation. GAB2 knock-in mice (mutated at PI3K or SHP2 binding sites) show both sites required for degranulation and anaphylaxis; PI3K (not SHP2) binding site is required for granule translocation. Fyn and GAB2/PI3K upstream of ARF1 constitute the pathway. SHP2 binding site is dispensable for granule translocation but required for degranulation.\",\n      \"method\": \"GAB2 knock-in mice (PI3K-binding-defective and SHP2-binding-defective), ARF1 activation assay, FcεRI degranulation assays, anaphylaxis model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — precise knock-in mice plus ARF1 activity assays plus in vivo functional readouts, multiple orthogonal methods\",\n      \"pmids\": [\"21653832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"G-CSF activates Lyn kinase through a Gab2-Shp2 complex: after G-CSF stimulation, Lyn dynamically associates with Gab2; Shp2 recruited by Gab2 dephosphorylates inhibitory phospho-Lyn Tyr507 to activate Lyn. A GAB2 mutant unable to bind Shp2 prevents Tyr507 dephosphorylation.\",\n      \"method\": \"Co-immunoprecipitation, Shp2-deficient cells, Shp2E76A constitutively active mutant, in vitro dephosphorylation assay, GAB2 Shp2-binding mutant\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro phosphatase assay plus genetic and mutant approaches, multiple orthogonal methods\",\n      \"pmids\": [\"21636860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In ovarian cancer cells, GAB2 promotes migration, invasion, and EMT via activation of the PI3K pathway. GAB2 inhibits E-cadherin expression and enhances Zeb1 expression through PI3K, not the Shp2-ERK pathway; Zeb1 knockdown blocks GAB2-induced E-cadherin suppression and invasion.\",\n      \"method\": \"GAB2 overexpression and knockdown, GAB2 mutants (PI3K-binding defective, SHP2-ERK pathway defective), Zeb1 knockdown, PI3K inhibitors (LY294002, GDC-0941, rapamycin), migration/invasion assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — structure-function mutants plus pathway-specific inhibitors plus downstream target knockdown, multiple orthogonal approaches\",\n      \"pmids\": [\"21996746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PKA phosphorylates GAB2 on Ser159, and GAB2 acts as an A-kinase anchoring protein that binds the type I regulatory subunit of PKA. GAB2 is present in a preformed complex with PI3K heterodimer and IRS-1 in granulosa cells. GAB2 overexpression enhances FSH-stimulated AKT phosphorylation, connecting cAMP-PKA signaling to the PI3K/AKT pathway.\",\n      \"method\": \"Co-immunoprecipitation (PKA regulatory subunit with GAB2), GAB2 overexpression, FSH-stimulated AKT phosphorylation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus functional overexpression assay, single lab, novel mechanism\",\n      \"pmids\": [\"23045700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RSK (p90 ribosomal S6 kinase) phosphorylates GAB2 on three conserved basic consensus residues in vitro and in vivo, inhibiting SHP2 recruitment to GAB2 without affecting GRB2 binding. An unphosphorylatable GAB2 mutant promotes invasion-like phenotype and increased cell motility, establishing RSK as a negative-feedback kinase for GAB2-SHP2 signaling.\",\n      \"method\": \"In vitro kinase assay (RSK phosphorylating GAB2), mass spectrometry phosphorylation site mapping, site-directed mutagenesis, co-immunoprecipitation, cell motility assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay plus MS site mapping plus mutagenesis plus functional assays, multiple orthogonal methods\",\n      \"pmids\": [\"23401857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A small-molecule (ISIR-005) stabilizes the 14-3-3/GAB2 protein-protein interaction by binding at the rim of the interface near the Gab2pT391 binding site. Crystal structure reveals ISIR-005 occupies a pre-formed pocket only at the pT391 site (not the pS210 site), providing structural proof of druggability of this interaction.\",\n      \"method\": \"Crystal structure of ISIR-005/14-3-3/Gab2pS210pT391, isothermal titration calorimetry\",\n      \"journal\": \"ChemMedChem\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with biochemical validation by ITC, rigorous structural evidence\",\n      \"pmids\": [\"26644359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GAB2 interaction with mutant SHP2 (E76K/D61Y) is enhanced, and the Gab2/PI3K/mTOR pathway is elevated in Ptpn11E76K/+ leukemic cells. Double mutant Ptpn11E76K/+/Gab2-/- mice show markedly attenuated myeloproliferative neoplasia, normalized myeloid differentiation, and prolonged survival. Rapamycin treatment mitigates MPN phenotypes, confirming the mTOR pathway mediates pathogenic signaling.\",\n      \"method\": \"Ptpn11E76K/+/Gab2-/- double mutant mice, rapamycin treatment, co-immunoprecipitation, myeloid colony assays, histology\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic double mutant mice plus pharmacological validation plus Co-IP, multiple orthogonal methods\",\n      \"pmids\": [\"27840422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In BCR-ABL1 leukemogenesis, distinct GAB2 signaling pathways are required for myeloid vs. lymphoid transformation: both PI3K and SHP2 binding sites of GAB2 are required for CML pathogenesis, while only the SHP2 binding site is essential for lymphoid leukemogenesis. Gab2-/- mice fail to develop CML-like disease after BCR-ABL1 transduction.\",\n      \"method\": \"Gab2-/- mouse models of CML and B-ALL, GAB2 mutants (PI3K binding-defective, SHP2 binding-defective), GAB2 re-expression rescue, signaling analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus rescue with domain-specific mutants in two distinct disease models, multiple orthogonal methods\",\n      \"pmids\": [\"26773044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"YAP/TAZ transcription regulators upregulate GAB2 expression; coordinate knockdown of YAP and TAZ markedly decreases GAB2 protein levels and reduces PI3K pathway activation in endometrial cancer cells, establishing a HIPPO-YAP/TAZ-GAB2-PI3K signaling axis.\",\n      \"method\": \"siRNA knockdown of YAP and TAZ, GAB2 protein level measurement, PI3K/AKT pathway assays, in vivo tumor growth\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with signaling readouts and in vivo validation, single lab\",\n      \"pmids\": [\"28202507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GAB2 overexpression in zebrafish MYCN-transgenic neuroblastoma activates the SHP2-RAS-ERK pathway, enhances neuroblastoma induction, and increases tumor penetrance. GAB2 functions as an activator of SHP2 that cooperates with MYCN in neuroblastomagenesis.\",\n      \"method\": \"Zebrafish MYCN transgenic model with Gab2 overexpression, ERK pathway activation analysis, tumor penetrance/latency assessment\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo zebrafish model plus signaling analysis, single lab\",\n      \"pmids\": [\"28329685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Gab1 and Gab2 are recruited to the IL-4 receptor and synergistically enhance IL-4 downstream signaling but confer IL-4 signal preference in macrophages. Loss of Gab2 specifically suppresses STAT6 activation (while Gab1 loss attenuates AKT) in response to IL-4, defining non-redundant roles in M2 polarization.\",\n      \"method\": \"Gab2-/- mice, Gab1 conditional knockout in macrophages, IL-4 signaling assays (STAT6, AKT), M2 polarization markers, bleomycin fibrosis model, co-immunoprecipitation with IL-4 receptor\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockouts for both Gab1 and Gab2 with multiple signaling readouts and in vivo phenotype\",\n      \"pmids\": [\"28687632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GAB2 facilitates assembly of the CBM (CARMA3-BCL10-MALT1) signalosome in endothelial cells, mediating Rho and NF-κB activation downstream of IL-1β. GAB2 silencing or MALT1 inhibition reduces IL-1β-induced Rho-dependent P-selectin/VWF exocytosis and NF-κB-dependent tissue factor expression. Gab2 deficiency suppresses venous thrombosis in IVC ligation mouse models.\",\n      \"method\": \"siRNA knockdown of Gab2 and MALT1, MALT1 pharmacological inhibitor (mepazine), co-immunoprecipitation (CBM signalosome assembly), endothelial exocytosis/adhesion assays, IVC ligation stenosis/stasis mouse models\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockdown plus pharmacological inhibition plus Co-IP plus in vivo mouse model, multiple orthogonal methods\",\n      \"pmids\": [\"35895897\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GAB2 is a scaffolding/docking protein that, upon tyrosine phosphorylation by receptor-associated kinases (including Src/Lyn, ZAP-70, JAK2, JAK3, Hck, and RSK), recruits SHP2, PI3K (p85), GRB2, PLCγ, CrkL, and other SH2-domain proteins to activate the PI3K/AKT and RAS/ERK/SHP2 signaling cascades downstream of diverse receptors (FcεRI, RANK, c-Kit, BCR-ABL, EGFR/HER2, IL-2R, G-CSFR, and others); its activity is negatively regulated by PKB/AKT-mediated Ser159 phosphorylation, by 14-3-3 binding at Ser210/Thr391 (which disrupts GRB2 association and receptor coupling), and by RSK-mediated phosphorylation that blocks SHP2 recruitment, while GAB2 itself uses its PH domain for membrane/phagosome localization, its MBD/PXXXR motif for Gads/GRB2-mediated LAT recruitment, and its SHP2-binding sites to activate the Rac/JNK pathway, promote RhoA suppression via p190A RhoGAP, facilitate CBM signalosome assembly for NF-κB/Rho activation, and ultimately control mast cell allergic responses, osteoclastogenesis, FcγR phagocytosis, hematopoietic cell proliferation/differentiation, and tumor metastasis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GAB2 is a tyrosine-phosphorylated scaffolding/docking protein that couples diverse cytokine, antigen, growth-factor, and integrin receptors to the PI3K/AKT and SHP2/RAS/ERK signaling cascades, thereby controlling hematopoietic differentiation, mast-cell allergic responses, osteoclastogenesis, phagocytosis, and tumorigenesis [#0, #2, #20]. Upon receptor engagement GAB2 is recruited to the membrane through its N-terminal PH domain and through GRB2/Gads binding to a PXXXR motif in its MBD, and once tyrosine-phosphorylated it assembles SH2-domain effectors—SHP2 at Tyr614, p85/PI3K at multiple tyrosines, GRB2, CrkL, and PLCγ—into signaling complexes [#1, #8, #11, #13, #15, #31]. The SHP2-binding sites drive ERK activation and immediate-early gene transcription, activate the Rac/JNK pathway, and suppress RhoA via Vav2/p190A RhoGAP, while the PI3K-binding sites mediate AKT activation, granule translocation, and EMT, allowing GAB2 to partition signaling into distinct biological outputs [#17, #24, #34, #35, #37]. GAB2 is the principal PI3K activator downstream of FcεRI in mast cells, is required for c-Kit/SCF, M-CSF, RANK, IL-2/IL-4, BCR-ABL, and STAT5 signaling, and serves as the scaffold for RANK-driven NF-κB/Akt/JNK in osteoclasts and for CBM-signalosome assembly mediating IL-1β-induced Rho/NF-κB responses [#2, #4, #5, #19, #46]. GAB2 functions as a proto-oncogene amplifying RTK signaling: its overexpression promotes proliferation, invasion, and metastasis in breast, ovarian, melanoma, and neuroblastoma models, and its loss attenuates Neu/ErbB2-driven carcinogenesis and BCR-ABL/Ptpn11-mutant leukemias [#9, #20, #26, #41, #42]. GAB2 activity is restrained by multiple negative-feedback phosphorylation events: AKT/PKA phosphorylation at Ser159, 14-3-3 binding at Ser210/Thr391 that uncouples GAB2 from GRB2 and the receptor, and RSK phosphorylation that selectively blocks SHP2 recruitment [#9, #28, #39].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established GAB2's foundational identity as a receptor-induced scaffold whose SHP2 association is required to drive immediate-early gene transcription, defining a signaling route distinct from MAPK.\",\n      \"evidence\": \"Cloning, Co-IP, and dominant-negative SHP2-binding mutants with c-fos/Elk1/STAT5 reporters\",\n      \"pmids\": [\"9885561\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define which tyrosines mediate SHP2 binding\", \"Physiological receptor contexts not yet established\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined the modular architecture (N-terminal PH domain, phospho-dependent SHP2 and GRB2 binding) and showed GAB2 uncouples ERK from Elk-1 signaling.\",\n      \"evidence\": \"Reciprocal Co-IP plus Elk-1/SRE reporter assays with dominant-active Ras\",\n      \"pmids\": [\"10391903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Membrane-targeting mechanism of the PH domain not resolved\", \"Physiological receptor input undefined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified GAB2 as the dominant IL-2R-coupled SHP2/PI3K docking protein, linking it to a specific receptor (Tyr338 of IL-2Rβ) and kinase (JAK3).\",\n      \"evidence\": \"Co-IP, IL-2 receptor mutants, JAK3 inhibition/knockout in lymphocytes\",\n      \"pmids\": [\"10849428\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream functional consequence in primary lymphocytes not addressed\", \"Cytokine specificity mechanism unexplained\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Genetic knockouts revealed GAB2 as a non-redundant, receptor-specific scaffold: it is the principal FcεRI-coupled PI3K activator in mast cells and required for c-Kit and M-CSF-driven differentiation, while in T cells it negatively regulates TCR signaling.\",\n      \"evidence\": \"Gab2-/- mice with mast-cell degranulation/anaphylaxis and KitL/M-CSF signaling assays; Co-IP and mutant analysis in Jurkat/hybridoma T cells\",\n      \"pmids\": [\"11449275\", \"11861309\", \"11287610\", \"11572860\", \"11895767\", \"11035047\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic basis for opposite (positive vs negative) signaling outputs across cell types unresolved\", \"Membrane recruitment requirements not fully mapped\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Mapped the specific tyrosines coupling GAB2 to effectors and established GAB2 as a proto-oncogene under AKT negative feedback, while implicating it in BCR-ABL leukemogenesis.\",\n      \"evidence\": \"Yeast two-hybrid tyrosine mapping; in vitro PKB kinase assay with S159A mutant and focus-forming assay; Gab2-/- bone marrow BCR-ABL transformation with Y177F mutant\",\n      \"pmids\": [\"11334882\", \"11782427\", \"12124177\", \"11830491\", \"11971018\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Ser159 phosphorylation mechanistically suppresses tyrosine phosphorylation not detailed\", \"Whether negative-feedback loops operate in all receptor contexts unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Resolved GAB2 membrane/phagosome recruitment logic and the LAT-coupling mechanism, and linked GAB2 to Rho-family GTPase regulation.\",\n      \"evidence\": \"Gab2-/- macrophage phagocytosis with confocal imaging and PH/GRB2 mutants; Gads/Grb2 PXXXR-motif raft recruitment in T cells; yeast two-hybrid identification of GC-GAP\",\n      \"pmids\": [\"12821647\", \"12640133\", \"12819203\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct contribution of GC-GAP to GAB2-dependent GTPase output in cells not established\", \"Spatial coordination of PI3K-dependent recruitment with effector assembly incomplete\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Pinpointed Tyr614 as the critical SHP2-docking site required for ERK activation and identified Src-family kinase (Hck) phosphorylation as essential for IL-6-driven GAB2 signaling.\",\n      \"evidence\": \"Tyr-to-Phe Co-IP mutants with ERK/SRE assays; kinase-inactive Hck and PP2 inhibition in myeloma cells\",\n      \"pmids\": [\"15170389\", \"15010462\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab studies without genetic confirmation\", \"Relative contribution of Tyr614 vs Tyr643 not fully separated\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Established GAB2 as a tissue-level disease scaffold: essential for RANK-driven osteoclastogenesis, an amplifier of RTK signaling in breast epithelium, and a driver of ErbB2/Neu-evoked carcinogenesis, while also coupling to STAT5.\",\n      \"evidence\": \"Gab2-/- osteopetrosis mice with RANK Co-IP; 3D MCF-10A morphogenesis with domain mutants; Gab2-/- in Neu-transgenic breast cancer; STAT5/PI3K Co-IP with 3YF mutant\",\n      \"pmids\": [\"15750601\", \"16369543\", \"16253990\", \"15833084\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why specific receptors route through PI3K vs SHP2 arms not mechanistically unified\", \"STAT5-driven GAB2 phosphorylation kinase identity uncertain\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Dissected the SHP2-dependent Rac/JNK arm downstream of Kit and the PLCγ2 requirement for RANK signaling, separating parallel PI3K and SHP2 pathways genetically.\",\n      \"evidence\": \"Gab2/SHP2 conditional knockouts and Kit Y719F/Y567 compound mice; Plcg2-/- mice with U73122 inhibition in osteoclasts\",\n      \"pmids\": [\"16873377\", \"17053833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PLCγ2-GAB2 binding interface not structurally defined\", \"How distinct Kit tyrosines partition GAB2 effector output incompletely understood\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Extended GAB2's oncogenic and signaling repertoire to ErbB2-driven metastasis, Stat3 activation in erythroleukemia, and suggested a neuronal role in tau regulation.\",\n      \"evidence\": \"Gab2-/- rescue in Neu metastasis model; Sf-Stk/Stat3 binding-site analysis in Friend erythroleukemia; siRNA and IHC in Alzheimer's brain\",\n      \"pmids\": [\"17310989\", \"17353274\", \"16314834\", \"17553421\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Neuronal tau finding rests on a single siRNA experiment with indirect readout, not independently confirmed\", \"Mechanism linking GAB2-ERK specifically to metastasis vs proliferation incomplete\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined 14-3-3 binding at Ser210/Thr391 as a second negative-feedback module that uncouples GAB2 from GRB2/receptor, and refined receptor-coupling determinants and kinase inputs.\",\n      \"evidence\": \"Phosphoproteomics, S210A/T391A and constitutive-binding knock-in mutants with transformation assays; Lyn/c-Cbl Co-IP in imatinib-resistant CML; c-Kit splice-form PI3K comparison\",\n      \"pmids\": [\"19172738\", \"18235045\", \"18697750\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of the multiple feedback loops (Ser159, 14-3-3, RSK) into a single regulatory model not addressed\", \"In vivo relevance of 14-3-3 feedback to tumorigenesis untested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Provided structural basis for the GAB2-GRB2 interaction and extended GAB2's pro-metastatic and osteoclast scaffolding roles via PI3K-AKT and RANK-HCR-PLCγ2.\",\n      \"evidence\": \"Crystal structures of Gab2a/b-Grb2SH3C with ITC; GAB2 gain/loss-of-function in melanoma xenografts; RANK HCR domain mutants with NFATc1/NF-κB assays\",\n      \"pmids\": [\"19523899\", \"19342374\", \"19845770\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length GAB2 structure and multivalent complex architecture unresolved\", \"How two distinct GRB2-binding modes are used contextually unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined the mechanism by which GAB2 suppresses RhoA—SHP2-dependent Vav2 phosphorylation and p190A RhoGAP membrane recruitment—linking GAB2 to cytoskeletal remodeling and migration.\",\n      \"evidence\": \"GAB2 SHP2-binding mutants, RhoA/Rac-GTP pulldowns, constitutively active RhoA rescue and p190A knockdown\",\n      \"pmids\": [\"21118992\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this RhoA-suppression axis operates in vivo during metastasis untested\", \"Connection to earlier GC-GAP finding not reconciled\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Genetic knock-in mice resolved the division of labor between GAB2's PI3K and SHP2 binding sites in mast-cell function (granule translocation vs degranulation) and defined an ARF1 effector arm, while linking GAB2-SHP2 to Lyn activation in G-CSF signaling and EMT in ovarian cancer.\",\n      \"evidence\": \"PI3K- and SHP2-binding-defective GAB2 knock-in mice with ARF1 assays/anaphylaxis; Shp2-dependent Lyn Tyr507 dephosphorylation assays; pathway-specific GAB2 mutants and Zeb1 knockdown in ovarian cancer\",\n      \"pmids\": [\"21653832\", \"21636860\", \"21996746\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generalizability of site-specific functional partitioning across other receptors not established\", \"Structural basis for effector selectivity unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified GAB2 as a PKA anchoring protein, connecting cAMP-PKA signaling to the PI3K/AKT pathway and reinforcing Ser159 as a convergent regulatory site.\",\n      \"evidence\": \"Co-IP of PKA RI subunit with GAB2 and FSH-stimulated AKT assays in granulosa cells\",\n      \"pmids\": [\"23045700\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab Co-IP without reciprocal structural validation of the AKAP function\", \"Functional consequence of AKAP activity in vivo untested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established RSK as a third negative-feedback kinase that selectively blocks SHP2 recruitment to GAB2 without disrupting GRB2 binding, restraining the pro-invasive SHP2-ERK arm.\",\n      \"evidence\": \"In vitro RSK kinase assay, MS site mapping, mutagenesis, Co-IP, and motility assays\",\n      \"pmids\": [\"23401857\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crosstalk between RSK, AKT, and 14-3-3 feedback loops not integrated\", \"In vivo tumor relevance of RSK feedback untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated druggability of the 14-3-3/GAB2 interface by stabilizing it pharmacologically at the pThr391 site, validating the feedback complex as a therapeutic target.\",\n      \"evidence\": \"Crystal structure of ISIR-005/14-3-3/Gab2 with ITC\",\n      \"pmids\": [\"26644359\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular and in vivo efficacy of interface stabilization not demonstrated\", \"Selectivity over other 14-3-3 client interactions unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Genetic double-mutant models defined GAB2 as a required effector of oncogenic SHP2 (Ptpn11E76K) via PI3K/mTOR and dissected distinct PI3K- vs SHP2-site requirements for myeloid versus lymphoid BCR-ABL leukemogenesis.\",\n      \"evidence\": \"Ptpn11E76K/+/Gab2-/- mice with rapamycin; Gab2-/- CML/B-ALL models with domain-specific mutant rescue\",\n      \"pmids\": [\"27840422\", \"26773044\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why lymphoid transformation requires only the SHP2 arm mechanistically unexplained\", \"Therapeutic targeting of GAB2 in these leukemias not tested clinically\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Broadened GAB2's tumor and immune roles: it cooperates with MYCN via SHP2-RAS-ERK in neuroblastoma, lies downstream of YAP/TAZ feeding PI3K in endometrial cancer, and confers IL-4 signal preference (STAT6) for macrophage M2 polarization.\",\n      \"evidence\": \"Zebrafish MYCN/Gab2 model; YAP/TAZ knockdown with GAB2/PI3K readouts; Gab1/Gab2 knockouts with IL-4/STAT6 signaling and bleomycin fibrosis\",\n      \"pmids\": [\"28329685\", \"28202507\", \"28687632\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect transcriptional regulation of GAB2 by YAP/TAZ not dissected\", \"Mechanism of GAB2-specific STAT6 coupling unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined a vascular role for GAB2 as a CBM-signalosome assembly scaffold mediating IL-1β-induced Rho/NF-κB signaling and thrombosis, extending GAB2 beyond hematopoietic and tumor contexts.\",\n      \"evidence\": \"Gab2/MALT1 knockdown, mepazine inhibition, CBM Co-IP, endothelial exocytosis assays, and IVC ligation thrombosis mouse models\",\n      \"pmids\": [\"35895897\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct GAB2 binding partner within the CBM complex not mapped\", \"Whether canonical PI3K/SHP2 sites are required for CBM assembly untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple negative-feedback phosphorylation events (Ser159 by AKT/PKA, Ser210/Thr391 by 14-3-3, RSK sites) are integrated to set GAB2's quantitative signaling threshold, and how GAB2 selects between PI3K and SHP2 effector arms in a given receptor context, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified structural model of full-length GAB2 in a receptor complex\", \"Cross-regulation among feedback kinases not reconstituted\", \"Determinants of PI3K vs SHP2 arm selection across receptors undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1, 5, 13, 21]},\n      {\"term_id\": \"GO:0005515\", \"supporting_discovery_ids\": [11, 31]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [17, 24, 34, 36]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [10, 13]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8, 10, 13, 34]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 13, 21]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 8, 13, 45]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [20, 26, 32, 41, 42]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 19]}\n    ],\n    \"complexes\": [\n      \"CBM (CARMA3-BCL10-MALT1) signalosome\",\n      \"GAB2/SHP2/PI3K(p85)/GRB2 receptor complex\",\n      \"14-3-3/GAB2 complex\"\n    ],\n    \"partners\": [\n      \"SHP2/PTPN11\",\n      \"PIK3R1/p85\",\n      \"GRB2\",\n      \"PLCG2\",\n      \"CrkL\",\n      \"LYN\",\n      \"STAT5\",\n      \"14-3-3\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}